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ABSTRACT
Signal transduction, the process by which an extracellular signal is
translated into an intracellular message, underlies all brain function.
This thesis examines the role of protein phosphorylation in mediating
three different molecular mechanisms by which neurotransmitter receptors
transduce their signals: chemically-gated ion channels, receptor-linked
ion channels and receptor-linked ion pumps.
The nicotinic acetylcholine receptor, a neurotransmitter-gated ion
channel, is phosphorylated by a protein tyrosine kinase in postsynaptic
membranes in vitro and in vivo. Purified nicotinic receptor molecules
from Torpedo electroplaques can be phosphorylated to known stoichiometries
and reconstituted into lipid vesicles. Tyrosine phosphorylation increases
the rate of the rapid phase of desensitization of the receptor as measured
by single channel recording but does not alter other channel properties.
These data provide direct evidence for the regulation of ion channel
properties by tyrosine phosphorylation and suggest that tyrosine-specific
protein phosphorylation, in addition to regulating cell transformation and
proliferation, may regulate neuronal signal transduction.
Medium spiny neurons, the principal cell type of the neostriatum,
contain DI and D2 dopamine receptors. D2 receptor activation is coupled
in dissociated neurons to an outward, voltage-dependent, transient K+
conductance, probably lA, as measured by whole-cell patch clamping. This
D2 coupled current can be inhibited by micromolar concentrations of
forskolin suggesting that the receptor-channel linkage is regulated by
protein phosphorylation. This inhibition of the D2 signal transduction
I
pathway by an adenylate cyclase-mediated process may underlie the
electrophysiological antagonism of DI and D2 receptor activation in
striatum.
The activity of Na+ ,K+-ATPase, an ion pump which couples the
hydrolysis of ATP to the countertransport of Na+ and K+ ions across the
plasma membrane, can be measured in permeabilized dissociated neostriatal
neurons. The neurotransmitter dopamine, through a synergistic effect on
DI and D2 receptors, inhibits the Na+ ,K+-ATPase activity of isolated
striatal neurons. This mechanism appears to involve protein
phosphorylation since cAMP-dependent protein kinase activation mimics DI
receptor stimulation and phorbol ester treatment mimics the effect of
dopamine application. These data provide unequivocal evidence for
regulation by a neurotransmitter of a neuronal ion pump. They demonstrate
that synergism between DI and D2 receptor activation, which underlies many
of the electrophysiological and behavioral effects of dopamine in the
mammalian brain, can occur on the same neuron. In addition, the data
suggest that dopamine, in addition to its regulation of ion channels,




Mechanisms of Signal Transduction
Signal transduction, the process by which a cell converts a stimulus
into a response, is the very essence of neurobiology. In the mammalian
brain, ten billion cells each communicate by releasing neurotransmitters
or hormones that bind to specific receptors in postsynaptic target
neurons. Cells must then transduce this extracellular chemical signal
into an intracellular message that directly or indirectly alters their
physiological properties. One powerful way to affect neuronal
excitability is to regulate transmembrane electrochemical gradients.
Neurotransmitter receptors accomplish this task through three distinct
receptor mechanisms: chemically-gated ion channels, receptor-linked ion
channels and receptor-linked ion pumps.
Chemically-gated ion channels include the nicotinic acetylcholine
receptor, GABAA receptor, glycine receptor and the NMDA and kainate/
quisqualate subtypes of glutamate receptors. These receptors are
multimeric transmembrane complexes that comprise both a neurotransmitter
binding site and an ion channel. Recent cloning and sequencing of the
cDNAs for three of these receptors has suggested that they are members of
a receptor superfamily and share many structural features (Barnard et aI,
1987). For each of these receptors, the selective permeation of specific
ions serves as a signal by depolarizing or hyperpolarizing the subsynaptic
area of the cell. Chapter 2 describes experiments on the modulation of
the archetypal member of this class, the nicotinic acetylcholine receptor.
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Some receptors are indirectly coupled to ion channels via guanine
nucleotide binding proteins (G-proteins). Members of the G-protein linked
receptor family include a and fi adrenergic receptors, dopamine receptors,
muscarinic acetylcholine receptors and many neuropeptide receptors. Gene
cloning suggests that many or all G-protein coupled receptors are related
and share such features as seven transmembrane a-helical domains and a
cytoplasmic domain that activates neighboring G-proteins (Ross, 1989).
G-proteins exist in their basal state as an afi� trimer oligomer with GDP
bound to the a subunit. During activation following ligand binding to a
receptor, GDP is released and replaced with GTP and the trimer dissociates
to form two potential regulatory molecules, a-GTP and fi� (Gilman, 1987).
These activated G-proteins can either regulate ion channels directly or
regulate channels indirectly by inducing changes in the intracellular
levels of cyclic nucleotides, inositol polyphosphates and arachidonic acid
metabolites. The regulation of channel activity by the D2 dopamine
receptor, a Gi-linked receptor, is the subject of Chapter 3.
The existence of both chemically-gated ion channels and receptor­
linked ion channels provides many different possibilities for
extracellular agents to regulate the intracellular biochemical environment
(Figure 1). Most of these channels are in some way dependent on membrane
voltage and their activation, in turn, modulates membrane potential.
Electrical activity of neurons, however, is also dependent on the activity
of ion translocating enzymes and a third class of neurotransmitter
receptors is those that are linked to such ion pumps. Although pumps can








Figure 1 Receptor-ion channel interactions in excitable cells.
Receptors are grouped according to whether they directly gate ions through
channels that are part of the receptor complex or are linked via G­
proteins to separate channels. Ns is a stimulatory G-protein, No and Ni
are members of the inhibitory G-protein family and Np represents receptor­
mediated phosphoinositol breakdown. (From Neher, 1988)
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that changes the concentration of the ion that the pump transports, direct
regulation of ion pump kinetics by neurotransmitters has previously been
demonstrated only in the kidney where dopamine regulates epithelial Na+
transport by inhibiting the Na+,K+-ATPase (Aperia et al., 1987). Chapter
5 demonstrates that the dopamine receptor in brain uses this third class
of transduction mechanism which may also be used by receptors for opiates
and epinephrine (Hajek et al., 1990; Beach et al., 1987).
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CHAPTER 2
Protein Phosphorylation in the Nervous System
Protein phosphorylation, the reversible covalent addition of
phosphate molecules to hydroxylated amino acids, is a major mechanism of
the control of such varied cellular processes as glycogen metabolism,
protein synthesis and oncogenic transformation (for review, see Cohen,
1982; Hunter et al., 1985). All phosphorylation reactions have three
common components: a substrate that can exist in dephosphorylated or
phosphorylated form, a protein kinase that catalyzes the phosphorylation
of the substrate, and a protein phosphatase that catalyzes the reverse,
dephosphorylation, reaction. The addition of the negatively charged
phosphate molecule to the substrate induces local charge differences and
structural changes which may result in functional changes in the protein.
Phosphoproteins, protein kinases and protein phosphatases are all
highly enriched in the synaptic regions of neurons suggesting that protein
phosphorylation modulates or mediates synaptic transmission (Nestler et
al., 1984; Nairn et al., 1985). Across many species and brain regions,
protein phosphorylation has been shown to regulate the efficacy of
synaptic transmission both by modulating neurotransmitter release and by
altering either the sensitivity of receptors or their underlying effector­
coupling mechanisms (for review, see Hemmings et al., 1989). For example,
phosphorylation of the vesicle-associated protein, synapsin I, facilitates
neurotransmitter release in the squid giant synapse (Llinas et al., 1985)
and postsynaptic long term potentiation in hippocampal CAl neurons
requires activity of both protein kinase C and calcium/calmodulin-
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dependent protein kinase (Nicoll et aI, 1988).
Phosphorylation mediates signal transduction through a multi-step
amplification process as shown Figure 2 (Greengard, 1987). Extracellular
signals, or first messengers, such as neurotransmitters interact with
membrane bound receptors. This leads to increases in intracellular levels
of specific second messengers such as cAMP, cGMP, calcium and
diacylglycerol which, in turn, activate specific cAMP-dependent, cGMP-
dependent, calcium/calmodulin-dependent and calcium/diacylglycerol-
dependent protein kinases. These kinases phosphorylate a broad range of
neuronal proteins including neurotransmitter receptors, ion channels,
cytoskeletal proteins and synaptic-vesicle associated proteins. These
phosphorylated substrates, or third messengers, may be the immediate
effector for the biological response or they may in turn activate fourth,
fifth, sixth, etc. messengers.
Protein biochemistry has been a powerful tool to identify such
messenger molecules by studying the possible phosphorylation of known
proteins and identifying novel proteins that can be demonstrated to be
phosphorylated in response to physiological stimuli. To elucidate the
functional consequences of such phosphorylation reactions, however, is
often difficult since measuring the incorporation of 32p in proteins
extracted from cell homogenates is far removed from observing the effects
of phosphorylation in intact, living cells. Electrophysiology has
traditionally provided information about the functional state of neurons
in terms of current and voltage but little information about the
intracellular signalling and phosphorylation status of the cell.
Direct evidence for a role of protein phosphorylation in mediating
8
Extracellular signals
1st messengers: Neurotransmitters, hormones, nerve impulses
!





Calcium ____. Physiological effectors
� "- other than protein kinoses
Calmodulin � r Diacylglycerol Jr.t® �@ � LPhoSPha;dYIserine
Unknown
1




cAMP-dependent cGMP-dependent Co/calmodulin-dependent Ca/phosphatidylserine
+ + 'f� ,('r�\.








Figure 2 Signals in the nervous system. Extracellular signals produce
specific biological responses in target neurons via a series of
intracellular signals. First messengers such as neurotransmitters,
photons of light and membrane depolarization regulate intracellular levels
of second messengers that include cAMP, cGMP, calcium and diacylgylcerol.
These compounds activate a small family of kinases which phosphorylate, on
kinase-specific residues, a large number of proteins. These third
messengers, of which there are over seventy that are neuron-specific,
either directly modulate cell physiology or produce biological responses
by activating additional messengers. (From Greengard, 1987).
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neurotransmitter action has been obtai�ed by intracellular injection of
protein kinases into nerve cells. Each of the four maj or classes of
protein kinases that phosphorylate substrate proteins on serine or
threonine residues has been demonstrated, upon intracellular injection, to
mimic the physiological activation of nerve cells. cAMP-dependent protein
kinase decreases the conductance of serotonin regulated potassium channels
in Aplysia (Castelluci et al., 1980). cGMP-dependent protein kinase
mediates serotonin regulation of voltage sensitive calcium channels in
Helix (Paupardin-Tritsch et al., 1986). Calcium/calmodulin dependent
protein kinase facilitates neurotransmitter release in the terminal digits
of the squid giant synapse (Llinas et al., 1985). Calcium/diacylglycerol
dependent protein kinase (protein kinase C) enhances the voltage sensitive
calcium currents in Aplysia (DeRiemer et al., 1985). Dozens of examples
exist of experiments using microinjection of either kinases to mimic or
potentiate the actions of extracellular signals, or kinase inhibitors to
prevent such physiological responses. Wi th the notable exception of
hippocampal neurons in which protein kinase C injection elicits features
of long term potentiation (Hu et al., 1987), injection experiments have
been limited almost entirely to large, invertebrate neurons. Vertebrate
neurons are smaller and easily damaged by cell penetration with a
conventional micropipette.
The recent development of the patch clamp technique has dramatically
altered the approaches to studying protein phosphorylation-mediated
cellular events. Patch clamping was initially designed to resolve single
ion channels without shunt currents and excess background noise (Hamill et
al .• 1981a). Very fast unit currents can be measured by this method with
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high signal to noise ratios thereby permitting many kinetic parameters of
ion channel function to be quantified. The gigohm seal between the
electrode and membrane surface is not only electrically tight but
mechanically stable which permits the topological arrangement of small
patches of membrane. Receptor sites can be deliberately oriented either
inward or outward by manipulating the membrane/glass seal (Figure 3).
Biochemical agents can be applied to either side of the membrane during
single channel recording to reveal changes in channel conductance, open
probability or availability (Sakmann et al., 1984). The cell-attached
patch configuration can be used to investigate channel regulation by
neurotransmitters acting via second messengers. By applying
neurotransmitter to the cell membrane area outside the pipette, the
modulation of channels in the membrane patch in the pipette tip opening
can be examined. Such an approach has been used to demonstrate that
serotonin and cAMP close single potassium channels in Aplysia sensory
neurons (Siegelbaum et al., 1982).
To examine the role of protein phosphorylation in channel
modulation, protein kinases can be applied to the cytoplasmic membrane
surface of a membrane patch in the inside-out configuration. Activation
of calcium-dependent potassium channels by cAMP-dependent protein kinase
in Helix neurons has been shown with this technique (Ewald et al., 1985).
To prove, however, that it is the channel itself rather than a regulatory
molecule that is being phosphorylated, it is necessary to measure directly
the phosphorylation state of the ion channel. This can be accomplished in
a marriage of biochemistry and electrophysiology; channels are purified







Figure 3 Schematic illustration of the four configurations for recording
from a cell with a patch-clamp pipette. The cell attached configuration
is generated by pressing a fire polished glass pipette (opening diameter
approx 0.5 �M) against a clean membrane surface to form a high resistance,
gigohm, seal. Pulling the pipette away from the cell generates an inside­
out patch with the cytoplasmic side of the membrane facing outwards.
Alternatively, a brief pulse of suction or voltage can be applied to
rupture the membrane patch and form the whole cell configuration in which
the electode and cell interior are physically contiguous. If the cell is
adhered to a surface, pulling the electrode away from the cell causes the
membrane to reform in an outside-out orientation. (Modified from Hille,
1984 and Hammill et aI, 1981a)
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into lipid bilayers or vesicles for patch clamp recording. Chapter 3
presents data demonstrating functional modulation of the nicotinic
acetylcholine receptor by tyrosine phosphorylation using such a
reconstituted system.
An unanticipated use of the patch clamp technique has been the
abili ty to record from small and/or fragile cells in the "whole-cell"
configuration. Not only does this permit single electrode voltage and
current clamp measurements with an excellent signal-to-noise ratio, it
provides a method for infusing cells with compounds of interest since the
electrode and cell interior are physically contiguous. Ions, second
messengers and protein kinases and phosphatases can be loaded into cells
without the trauma of microelectrode impalement and pressure injection.
This technique has been used to provide direct evidence for protein
phosphorylation on neuronal function. For example, perfusion of spinal
cord neurons with the catalytic subunit of cAMP-dependent protein kinase
reduces the amplitude of GABAA evoked outward currents (Porter et al.,
1990). The experiments described in Chapter 4 extend this technique to
examine dopamine regulation of the basal ganglia by recording from
dissociated guinea pig striatal neurons with concomitant extra and
intracellular applications of protein phosphorylation-regulating agents.
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CHAPTER 3
Tyrosine Phosphorylation of the Nicotinic Acetylcholine Receptor
Regulates its Desensitization Rate
The nicotinic acetylcholine receptor (nAchR) is a receptor ion
channel complex that mediates the depolarization of the postsynaptic
membranes of nicotinic cholinergic synapses. The nAchRs from skeletal
muscle and electric organs are pentameric complexes of four types of
subunits in the stoichiometry Q2/3-yO. Each subunit is a transmembrane
protein that forms one stave of a pseudosymmetric barrel around a central
ion channel that is permeable to Na+, K+, and Ca* ions. The nAchR is
present at accessible neuromuscular junction synapses for
electrophysiological study and can be purified in hundred microgram
quantities from single electroplaques of electric fish for biochemical
assays, and therefore has become the model for the study of the structure,
function and regulation of chemically-gated ion channels (for review, see
Changeux et al., 1984).
Isolated postsynaptic membranes enriched in nAchR contain at least
four classes of protein kinases: cAMP-dependent protein kinase,
calcium/calmodulin-dependent protein kinase, protein kinase C and a family
of tyrosine-specific protein kinases (Miles et al., 1988). Three of these
endogenous kinases stoichiometrically phosphorylate the nAchR. cAMP-
dependent protein kinase rapidly phosphorylates serine residues on the -y
and 0 subunits (Huganir et al., 1983a). Protein kinase C rapidly
phosphorylates a serine residue on the 0 subunit and more slowly
phosphorylates a serine residue on the Q subunit (Huganir et al., 1983b).
An endogenous tyrosine kinase rapidly phosphorylates tyrosine residues on
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the p, � and 6 subunits (Huganir et al., 1984). Each of these kinases
phosphorylates unique residues and thus the three kinases phosphorylate
the nAchR on a total of seven distinct sites.
All four subunits of the nAchR have been cloned from many different
species and are highly homologous to each other in their amino acid
sequence (eg, Noda et al., 1983). Several models of transmembrane
topology for the subunits have been proposed based on the hydropathy plots
of their amino acid sequences (Guy et al., 1987). Although such models
differ in the location of the carboxy terminus relative to the cell
interior and in the number of transmembrane domains, they share the
feature of a large intracellular loop between transmembrane Q helix M3 and
its neighbor (Figure 4a). Consensus sequences for the protein kinases
have suggested, and peptide sequencing has proven, that the seven residues
phosphorylated by the three kinases are located on this loop (Yee et al.,
1987; Huganir et al., unpublished observations). The close proximity of
these sites (the three sites on the 6 subunit are within 20 amino acids of
each other) suggests that the phosphorylation of the nAchR regulates a
common property of the receptor (Figure 4b). These phosphorylation sites
are conserved in the amino acid sequences of nAchR from all species except
for those on the � subunit which are not conserved in mammals (Miles et
al., 1988).
The physiological significance of phosphorylation of the nAchR was
first established by stop flow and quench flow kinetic experiments on
purified and reconstituted receptors. Such reconstituted receptors
maintain all the channel properties observed in vertebrate muscle
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Figure 4 Proposed secondary and sequenced primary structure of the
nAchR. A: One proposed model for the transmembrane topology of
individual subunits. P indicates the region of each subunit that is
phosphorylated by protein kinases. The P region is intracellular across
models of the transmembrane topology and thus conclusions about the
effects of phosphorylation are not model-dependent. B: Locations of the
phosphorylated amino acid residues on the a f3 '1 and 6 subunits. The
kinases and their phosphorylation sites are: cAMP-dependent protein kinase
('1:ser-373, 6:ser-36l), protein kinase C (a:ser-333, 6:ser-377), tyrosine
kinase (f3:tyr-355, '1: tyr-364 , 6:tyr-372). (From Huganir et al., 1987)
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the � and 0 subunits of the purified receptor by cAMP-dependent protein
kinase increases the rapid phase of receptor desensitization as measured
by 86Rb+ flux but does not change the initial rate of ion transport or the
dissociation constant of acetylcholine from its binding sites (Huganir et
al.,1986). Quench flow analysis provides information about rapid kinetic
events by measuring net flux but cannot determine channel open times or
conductances. The rate of desensitization can be determined from the
total flux rate only if mean channel current and open time are unchanged
across preparations. To examine in more detail what receptor parameters
change with phosphorylation, whole cell and single channel
electrophysiological techniques have been applied to the study of nAchR in
skeletal muscle. cAMP and forskolin (both activators of cAMP-dependent
protein kinase) and phorbol esters (activators of protein kinase C) have
been shown to increase the desensitization rate of acetylcholine-induced
whole-cell currents in situ (Middleton et al., 1986; Albuquerque et al.,
1986; Eusebi et al., 1985). Forskolin enhances receptor desensitization
through a second messenger pathway without changing the properties of
individual single-channel currents (Middleton et al., 1988).
In contrast, the functional role of tyrosine phosphorylation of the
nAChR has not been examined. Phosphorylation of proteins on tyrosine
residues regulates cell growth and transformation: cytoplasmic tyrosine­
specific protein kinases were first discovered as the protein products of
transforming retroviruses and many membrane-bound growth factor receptors
are tyrosine kinases (for review see Hunter at al., 1985 and Ullrich et
al., 1990). Although a number of substrate proteins are phosphorylated on
tyrosine residues, the functional alteration of proteins by tyrosine
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phosphorylation has previously been convincingly demonstrated only for
protein tyrosine kinases (Rosen et al., 1983; Courtneidge, 1985; Cooper et
al., 1986). A role for tyrosine phosphorylation in neuronal function
might seem unlikely because mammalian brain is a nonproliferative tissue
and phosphotyrosine constitutes as little as 0.01% of the total
phosphoaminoacids of proteins of normal cells (Bishop, 1983). However,
the normal cellular homologues of the src and yes viral oncogenes are very
abundant in adult brain and tyrosine phosphorylation of synaptic-vesicle
associated proteins can be seen in intact nerve terminals, suggesting that
tyrosine phosphorylation may be involved in signal transduction (Hirano et
al., 1988; Pang et al., 1988).
Highly purified postsynaptic membranes from Torpedo e1ectrop1aques
contain a very active protein tyrosine kinase activity which
phosphory1ates the nAchR on the �, � and 6 subunits in vitro (Huganir et
al., 1984). Isolated nAchR contain high levels of endogenous
phosphotyrosine (1.5 mole phosphotyrosine/mole receptor). Since the
tyrosine phosphorylated sites of the nAchR are close to the same sites
phosphorylated by cAMP-dependent protein kinase and protein kinase C, it
seemed possible that tyrosine phosphorylation of the receptor would also
regulate its desensitization rate. To analyze quantitatively the
functional effects of tyrosine phosphorylation of the receptor, small
unilamellar vesicles containing purified and reconstituted receptor from
Torpedo californica were fused by a simple freeze thaw procedure to form
large liposomes. Giga-seal patch-recording techniques were used to form
isolated inside-out patches of reconstituted liposome membrane and to




Postsynaptic membranes highly enriched in the nAchR were prepared by
subjecting freshly dissected and homogenized electric organs of Torpedo
californica to a discontinuous sucrose gradient (Huganir, 1984). The
postsynaptic membranes were diluted to 0.5 mg/ml with a phosphorylation
reaction mixture containing, in mM, 20 Tris-HCl, 10 MgC12, 2 MnC12, 1
ouabain, 1 sodium vanadate, 0.5 EGTA, 0.5 EDTA, 10 2-mercaptoethanol plus
100 nM cAMP-dependent protein kinase inhibitor (Walsh peptide) and 10
�g/ml each of leupeptin and antipain. To obtain an autoradiograph of 32p_
labelled tyrosine phosphorylated receptor, the phosphorylation reaction
was initiated with 0.5 mM [-y-32p]-ATP and carried out for 30' at 30°.
Samples were subjected to electrophoresis on 10% NaDodS04 polyacrylamide
gels and the incorporation of 32p quantified by liquid scintillation
spectrophotometry. Receptor preparations were treated with agents to
increase and decrease the stoichiometry of tyrosine phosphorylation from
the endogenous level. To increase phosphorylation levels, the membranes
were incubated with or without 0.5 mM ATP for 10' or 30' at 30°. The
reactions were stopped by rapid cooling to 4°C and centrifugation. The
pellets were resuspended at 2.5 mg/ml in 20 mM Tris-HCl pH 8.0, 20 mM
MgC12, 1 mM EDTA, 1 mM EGTA, 20 �g/ml leupeptin, 20 �g/ml antipain, 20
units/ml Trasylol and 0.3% Na-cholate. To dephosphorylate the membranes,
the suspended samples were incubated for 15' at 30°C with or without 0.25
or 0.5 mg/ml alkaline phosphatase.
To determine the stoichiometry of phosphotyrosine content of the
nAchR subunits, parallel assays were run comparing 125I-protein A labelling
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of phosphotyrosine residues with 32P-incorporation during the in vitro
phosphorylation (Hopfield et al., 1988). The nAChR was phosphorylated in
vitro using unlabelled ATP, purified and Western blotted using affinity
purified antiphosphotyrosine antibodies and 1251-protein A. The 1251_
protein A labelling of the f3, -y and 5 subunits under these conditions
measured both the endogenous phosphotyrosine residues in the subunits
prior to the in vitro phosphorylation and the phosphotyrosine residues
phosphorylated in vitro. The stoichiometry of 32p incorporation in each
of these samples was measured by conducting the in vitro phosphorylation
with -y32p-ATP of known specific activity. The specific activity of
1251-protein A labelling (CPM/mole phosphotyrosine) could then be
calculated by comparing the stoichiometry of 32P-incorporated with the
increase in 1251-protein A labelling of the nAchR upon in vitro
phosphorylation using the formula: [(CPM of 1251-protein A labelling of in
vitro phosphorylated subunit) - (CPM of 1251-protein A labelling of
nonphosphorylated subunit) ]/mole 32p-phosphate incorporated in vitro. From
this calculation, the stoichiometry of tyrosine phosphorylation of the
subunits of all the receptor preparations was determined to within 0.1
moles phosphotyrosine/mole receptor.
Receptor Purification and Reconstitution
The phosphorylated receptor was purified to over 95% homogeneity
from the Na-cholate extract using affinity chromatography on a choline
carboxymethyl affinity gel with 20 roM carbamylcholine as eluate. The
solubilized receptors were then incorporated via detergent dialysis into
small unilamellar asolectin vesicles (Huganir et al., 1982) for final
lipid-protein ratios in the range of 100: 1 to 50: 1 by weight. 50 #-'1
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aliquots of vesicles were suspended at a concentration of 20 to 25 mg
lipid per ml of a storage buffer containing, in mM, 100 NaCl, 50 KCl, 0.1
EDTA, 0.1 EGTA, 10 NaPi, pH 8.0, then rapidly frozen and stored in liquid
nitrogen.
Patch Clamp Recording
Aliquots of receptor were slowly thawed at 4°C overnight to permit
the formation of large, multilamellar liposomes. 0.5 �l portions were
spotted onto the center of the bottom of 35 rom plastic petri dishes and
covered with 2 ml of a salt solution containing (in mM) 150 NaCl, 1 CaC12,
1 MgC12, 10 HEPES, pH 7.2. The largest of the multilamellar liposomes
(>5.0 �m in diameter) were selected under phase contrast microscopy (400X)
for recording. Patch pipettes were pulled in a two step pull using a Kopf
720 vertical pipette puller from 100 �l Boralex glass (Rochester
Scientific) and fire polished with a Narishige microforge to a final
resistance of 10-20 Mohm. Pipettes were backfilled with the salt solution
plus varying concentrations of cholinergic compounds.
A patch clamp system, similar to that described by Hamill et ale
(198la), consisting of an Axopatch lA amplifier, Zeiss motorized
micromanipulator and a PDP 11-73 computer with a Cheshire data interface
and digital display was used to apply a holding voltage to the pipette
interior and record single channel currents. For each experimental trial,
a fresh non-agonist-exposed sample of liposomes was used. Seals were
formed by lowering the electrode to within 1 �m of the selected liposome
while maintaining positive pressure on the pipette interior and then
abruptly releasing the pressure which caused the liposome to "jump" onto
the electrode tip. Two seconds after seal formation (seal resistance> 25
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Gohm), the pipette holding potential was clamped at +100 mV and the
pipette was withdrawn several microns from the liposome, creating a
unilamellar inside-out patch. This two second delay was required for seal
stabilization. Currents were continuously sampled for 2 minutes at 4000
Hz (250 �sec/pt) and filtered at 1500 Hz (-3 dB, 8 pole Bessel filter).
Experiments were conducted at room temperature (18-22°C).
Data Analysis
Data were sampled, displayed, analyzed and plotted using a series of
eighteen homewritten Basic-23 programs. Following acquisition, data were
displayed in 128 msec blocks and the opening and closing of each channel
event measured as a function of time after seal formation.
Desensitization histograms of the number of channel events per time
interval (N(t» were created and fitted to exponential distributions using
a reiterative interactive X2 minimization routine. Histograms containing
at least 100 channel events over the 2 min. recording period were fitted
to the following equation:
N(t)- D [(ALB) e-t/B +(1-A/C) e-t/C]
Ae-2/B + (1-A)e-2/c
In this three variable fit, A � % fast exponential's contribution to the
observed exponential; B = r fast; C = r slow; D = total number of channel
events X histogram bin width. The denominator of the equation used is a
correction for the distribution of channel events missed in the two second
delay prior to data collection.
Histograms of open channel lifetimes were generated in a similar
fashion using a bin width of 0.5 msec and fitted to double exponential
distributions using a reiterative X2 fitting routine.
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RESULTS
The nAchR containing liposomes, when diluted into saline for
recording, formed a suspension of irregularly shaped bilayer structures
ranging in size from below the resolution of light microscopy to several
microns in diameter. The largest of these liposomes (5 �m in diameter)
that were free from surrounding lipid material were selected for patch
clamp recording. Such liposomes, as shown in Figure 5, exhibited complex
membrane topology with bilayer protrusions on their surfaces. Ion flux
assays have shown that in such bilayer structures, reconstituted receptors
have a uniform orientation with the acetylcholine binding sites facing
outward (Huganir et al., 1982).
The reconstituted nAchR displayed channel properties similar to
those previously reported (Tank et al., 1983): patches of liposome
membrane containing the nAchR displayed multiple channel openings
corresponding to a unitary inward 4.2 pA current when the pipette
contained 1 �M acetylcholine and the pipette interior was clamped at +100
mV (Figure 6a). No nAchR channel activity was ever observed in the
absence of either agonist (Figure 6b) or voltage or in pure liposomes
without reconstituted receptor. The reconstituted nAchR displayed the
established pharmacological responses to a variety of cholinergic
antagonists: bath application of 10 �M a-bungarotoxin prior to seal
formation, or the presence of 100 �M tubocurarine in the patch pipette,
blocked all channel activity. The inclusion of 500 �M procaine with
acetylcholine in the patch pipette greatly reduced the frequency of
channel openings (Figure 6c).
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Figure 5 Phase photomicrographs of liposomes containing nAchR
A: Suspension of liposomes of varying appearance and size. Scale bar 20 pm
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Figure 6 Pharmacology of nAchR channel activity. Traces are four
contiguous 0.512 sec portions of individual records sampled immediately
after seal formation and application of a +100 mV holding potential.
Traces are plotted atypically with inward current as an upward deflection.
The patch pipette contained, A: 1 J,LM acetylcholine B: 0 J,LM acetylcholine
c: 500 J,LM procaine and 1 J,LM acetylcholine.
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Plasma membrane vesicles from Torpedo, although most highly enriched
in nAchR, also contain voltage-gated chloride channels (Tank et al.,
1982). Such channels, readily distinguishable from nAchR by their 9 and
18 pS conductance substates, long open times, voltage dependence, agonist
independence and failure to desensitize, were observed in only five of
several hundred liposomes sampled (data not shown).
The frequency of acetylcholine-induced channel events in untreated
receptors with an endogenous phosphotyrosine content of 1.5 mole/mole
receptor diminished with time after seal formation and voltage application
(Figure 7, top). This desensitization behavior could be quantified from
histograms of the number of channel openings per unit time after seal
formation (Figure 7, bottom) and could be fitted to a sum of two
exponentials. Two desensitization processes, a rapid and a slow phase,
have previously been observed for the nicotinic acetylcholine receptor
both in situ and after reconstitution (Sakman et al., 1980; Hamill et al.,
1981a; Walker et al., 1982). Desensitization of the nAchR was very rapid
and channel events could be observed only if seal formation occurred
within the first few seconds of the pipette entering the bath solution and
if recording began immediately after seal formation. Such traces
typically contained several hundred channel events during the two minute
period of continuous recording. Recordings obtained after longer delays
to seal formation (> 10 sec) contained only a very low steady-state level
of channel activity.
The rates of the rapid and slow phases of desensitization were
dependent on the concentration of acetylcholine applied (Table I).
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Figure 7 Desensitization behavior of purified and reconstituted nAchR as
seen in single patches. Top: 0.512 sec portions of a single record
sampled 0, 15, 30 and 60 sec following seal formation and voltage
application. Pipette holding potential, +100 mV; 1 �M acetylcholine.
Bottom: exponential decay with time of the frequency of channel opening
events. The number of channel openings in successive 1.024 second
intervals was plotted versus the midpoint of these time intervals. The
dotted curve shows a double exponential distribution with rfast - 7.8 sec,
rslow - 30.2 sec, % fas t - 50. (From Hopfield et al., 1988)
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ACh, JLM "fast "slow % fast n
0.5 11.5(0.8) 28.8(3.9) 61(25) 4
1.0 6.5(0.9) 25.5(8.0) 71(15) 6
2.5 3.9(0.8) 20.9(1.5) 68(19) 4
5.0 1.6(0.5) 12.0(2.2) 79(22) 6
Table I Acetylcholine concentration dependence of desensitization. Fast
and slow time constants (sees) were determined by double exponential fits
to histograms of channel openings over time. All experiments were
conducted with a single preparation of reconstituted receptor with a
stoichiometry of 0.5 mole phosphotyrosine per mole each of p, � and 6
subunits. Data are mean values (± standard deviations).
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and slow phases of desensitization. The observed rates and dose
dependence of both phases of desensitization were consistent with the
rates and dose dependence of desensitization of the nAchR from Torpedo
determined using rapid mixing ion flux techniques (Walker et al., 1982).
Experiments were confined to a narrow agonist concentration range of 0.5
to 5.0 �M. Below 0.5 �M, the slow desensitization process dominated and
the total number of channel events was too low for exponential analysis
and above 5.0 �M, desensitization was so fast that the initial decay of
channel activity occurred during the several second seal formation
procedure followed by only occasional channel bursting behavior. The
optimal concentration of acetylcholine that yielded a large total number
of channel events and enabled determination of both phases of
desensitization was 1 �M which was therefore used for subsequent
experiments.
The nAchR from Torpedo californica is phosphorylated on tyrosine
residues to a high stoichiometry in vivo (Smith et al., 1987). To
determine the endogenous phosphotyrosine content of the purified nAchR,
quantitative irnrnunoblotting techniques employing an anti-phosphotyrosine
affinity purified antibody were used (Hirano et al., 1988; Ohtsuka et al.,
1984). The purified nAchR contained 0.9-1.5 moles of endogenous
phosphotyrosine per mole of receptor depending on the preparation. The
phosphotyrosine was distributed among the �, �, and 5 subunits (Figure 8,
lane 5). This endogenous phosphotyrosine content could be decreased in
vitro by treatment of the nAchR with alkaline phosphatase (Figure 8, lanes
3 and 4). Under the conditions used, alkaline phosphatase did not
dephosphorylate nAchR phosphorylated in vitro on serine residues by
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Figure 8 Purified nAchR preparations with various stoichiometries of
tyrosine phosphorylation (from Hopfield et al., 1988)
Lane 1: Protein stain of purified receptor preparation
Lane 2: Autoradiograph of 32P-labeled tyrosine phosphorylated receptor
Lanes 3-7: Western blot analysis of nAchR preparations with increasing
phosphotyrosine content using affinity-purified anti-phosphotyrosine
antibody
Lane 3: in vitro phosphatase-treated nAchR (0.50 mg/ml)
Lane 4: in vitro phosphatase-treated nAchR (0.25 mg/ml)
Lane 5: untreated receptor
Lane 6: phosphorylation reaction mixture-treated nAchR (10')
Lane 7: phosphorylation reaction mixture-treated nAChR (30')
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protein kinase C or by the catalytic subunit of cAMP-dependent protein
kinase using �-32ATP. Conversely, the stoichiometry of tyrosine
phosphorylation of the receptor could be increased in vitro by
phosphorylation of the receptor using the endogenous protein tyrosine
kinase activity in the postsynaptic membrane (Figure 8, lanes 2, 6 and
7). Using a combination of these dephosphorylation and phosphorylation
procedures, purified receptor preparations with a broad range of
stoichiometries of tyrosine phosphorylation were prepared and
reconstituted into phospholipid vesicles. Samples with eight different
stoichiometries ranging from 0.6 to 2.7 moles phosphotyrosine/mole
receptor were used for recording and analyzed for changes in channel
kinetics.
The rate of desensitization of the nAchR showed a striking
dependence on the stoichiometry of tyrosine phosphorylation. Examples of
data recorded from two individual patches of reconstituted receptor with
stoichiometries of tyrosine phosphorylation of 0.6 and 2.3 moles
phosphate/mole receptor are shown in Figure 9. The overall rate of
desensitization was dramatically increased with increased stoichiometries
of phosphorylation. The major portion of this effect was on the rapid
phase of desensitization which showed a seven-fold change in rate over the
range of stoichiometries of tyrosine phosphorylation examined (Figure
10). In addition, a two-fold change in the slow rate of desensitization
was observed (Table II). The subunits appear to contribute equally to the
overall desensitization rate of the receptor: two receptor preparations
which had identical total stoichiometries of 1.5 moles phosphotyrosine/
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Figure 9 Tyrosine phosphorylation modulates the rate of desensitization
of the nAchR as measured by exponential decay with time in the frequency
of channel opening events. Pipette holding potential +100 mV; 1 #lM
acetylcholine. Top: 0.6 moles phosphotyrosine/mole receptor. Fitted
double exponential: Tfast"" 15.1 sec, Tslow = 32.4 sec, % fast == 76. Bottom:
2.3 moles phosphotyrosine/mole receptor. Fitted double exponential: Tfast






















Figure 10 Increased levels of tyrosine phosphorylation increase the rate
of the rapid phase of desensitization. Time constants of the rapid phase
of desensitization are plotted versus the stoichiometry of tyrosine
phosphorylation. Data are plotted as mean values ± standard deviations.
(From Hopfield et al., 1988)
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Total Subunit Stoich.
Stoich. f3 -y 0 r fast r slow % fast n
0.6 .2 .1 .3 15.3 (0. 7) 36.3(8.7) 87(11) 4
0.9 .3 .3 .3 9.7(0.9) 23.1(4.3) 86(13) 3
1.5 .6 .3 .6 7.2(1.2) 23.6(3.1) 45(22) 6
1.5 .5 .5 .5 6.9(0.9) 25.5(8.0) 71(15) 6
1.8 .6 .5 .6 5.4(1.1) 20.6(8.1) 87(8) 7
2.0 .7 .5 .8 2.9(0.2) 19.9(6.7) 44(25) 6
2.3 .7 .7 .9 2.7(1.4) 19.1(2.7) 40(9) 4
2.7 .9 .9 .9 2.2(0.6) 14.8(2.7) 55(21) 3
Table II Effect of tyrosine phosphorylation on the fast and slow time
constants (sees) of desensitization. Pipette holding potential +100 mV;
l�M acetylcholine. All experiments at a given stoichiometry (moles
phosphotyrosine/mole receptor) were conducted with a single preparation of
reconstituted receptor. All data are mean values (± standard deviations).
(From Hopfield et a1., 1988)
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subunits, had nearly identical desensitization rates (Table II).
Tyrosine phosphorylation of the nAchR had no detectable effect on
other parameters of ion channel function. Open time analysis of nAchR in
a single patch from records without simultaneous channel openings
indicated that most open channel lifetimes were in a range from 1-15
msec. Histograms of the frequency of open channel lifetimes, generated by
pooling all single channel openings observed across experiments with a
given stoichiometry of phosphorylation, indicate that the open channel
distributions could be fitted to the sum of two exponentials with
characteristic fast and slow time constants of 1 and 7 msec respectively.
Figure 11 illustrates two such histograms for receptors with 0.6 and 2.3
moles phosphotyrosine/mole receptor. The apparent mean channel open-time
distributions and single channel conductances were essentially identical
in all of the receptor preparations examined (Table III) and similar to
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Figure 11 Open channel lifetimes of single channel events from records
pooled across all experiments conducted at a given stoichiometry of
tyrosine phosphorylation. Pipette holding potential +100 mV; 1 J..LM
acetylcholine. Top: 0.6 moles phosphotyrosine/mole receptor. Fitted
double exponential: Tfast=l.l msec, TSlow=7. 3 msec, % fast=80. Bottom: 2.3
moles phosphotyrosine/mole receptor. Fitted double exponential: Tfast- 0.8
msec, Tslow=7. 0 msec, % fast=83.
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Total Total events conductance
Stoich. r fast 1'slow % fast examined n pS
0.6 1.1 7.3 80 1971 4 42
1.5 0.9 5.8 91 4720 6 44
1.5 1.2 7.3 79 2035 3 42
2.3 0.8 7.0 83 1516 4 43
2.7 0.9 6.9 86 725 3 40
Table III Effect of tyrosine phosphorylation on single channel properties
of the nAchR. All single channel openings across n separate experiments
from a receptor preparation at a given stoichiometry were pooled. Fast
and slow time constants (msec) of open channel lifetimes were determined




The data in Figure 10 and Table II suggest that the effect of
phosphorylation of each subunit is additive and that the more highly
phosphorylated species of the nAchR desensitize at more rapid rates.
Kinetic interpretations of the data are complicated by the fact that the
calculated stoichiometries of tyrosine phosphorylation are non-integer
numbers that represent composites of receptors with integer values of
phosphorylation. Given the assumption that the phosphorylation/
dephosphorylation of individual subunits occurs independently of each
other, each receptor preparation would consist of eight different receptor
populations, present in varying proportions and ranging in the number (0-
3) of phosphates per receptor and in the individual subunits
phosphorylated. As shown in Table IV, the probability of phosphate
occupancy at the three potential phosphorylation sites can be calculated
for the different stoichiometries of phosphorylation. With increasing
stoichiometry, the percentage of triply phosphorylated receptor increases
while the percentage of non-phosphorylated receptor decreases. The
percentage of singly and doubly phosphorylated receptor first increases
and then decreases with increasing stoichiometry of phosphorylation.
These calculations assume phosphorylation only on tyrosine residues since
phosphorylation on serine residues was extremely low (0 to 0.1 mole
phosphoserine/mole receptor) and did not change with treatment to regulate
the level of tyrosine phosphorylation.
The measured rates of desensitization presumably represent
composites of the rates of desensitization of these variously
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Total Subunit Stoich. Probabili ty of sites phosphorylated
Stoich. f3 "Y 5 0 1 2 3
0.6 · 2 .1 . 3 .50 .40 .10 .00
0.9 · 3 · 3 .3 .34 .44 .19 .03
1.5 .6 .3 . 6 .11 .38 .40 .11
1.5 .5 · 5 .5 .12 .38 .38 .12
1.8 .6 .6 .6 .06 .29 .43 .22
2.0 · 7 .5 .8 .03 .22 .47 .28
2.3 · 7 · 7 .9 .00 .12 .43 .44
2.7 · 9 .9 .9 .00 .03 .24 .73
Table IV Probability of phosphate occupation of the three potential
phosphorylation sites at different stoichiometries of phosphorylation.
Assuming that the sites are independent, the probabilities can be
calculated from the following formulae:
P3 sites = P,eP7P c5
Pz sites .... P,eP7(1-Pc5)+P,ePc5(I-P7)+P7Pc5(1-P,e)
P1 site =: P,e(I-P7) (1-Pc5)+P7(1-P,e) (I-Pc5)+Po(l-P,e) (1-P7)
Po sites = (l-P,e) (I-P7) (I-Po)
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phosphorylated species. The rapid and slow phases of desensitization
would themselves be expected to be of multi-exponential character
reflecting the multiple phosphorylation states of the receptor. However,
the relatively low number of channel events per patch does not permit such
complex exponential analysis.
The contributions of these subpopulations are particularly important
when considering the accuracy of the rapid rates of desensitization
measured for the highly phosphorylated preparations. Most of the records
from patches isolated from such preparations showed few channel events due
to the extremely rapid rate of desensitization. In such cases, most of the
channel openings appear to have occurred during the several second delay
prior to data collection inherent in the recording paradigm because when
patches were isolated with an unusually short delay, a significant portion
of the rapid phase of desensitization could be observed. For the most
highly phosphorylated preparation used (2.7 moles phosphotyrosine/mole
receptor), 73% of the receptor molecules would be expected to be
phosphorylated on the p, � and 5 subunits. It is possible that the two
second time constant observed may be largely determined by the 27% of the
nAchR molecules not phosphorylated on all three subunits and therefore,
the rate constant of the rapid phase of desensitization for the triply
phosphorylated receptor may be considerably faster than the two seconds
determined for this preparation. Flux analysis of fast desensitization
kinetics from these liposomes will be required to resolve this issue.
Tyrosine phosphorylation of the nAchR had no effect on the open time
distributions of single channel events (Table III). Increased probability
of channel opening with phosphorylation by cAMP-dependent protein kinase
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in nAchR reconstituted into lipid bilayers has been reported (Montal et
al., 1987). Such experiments, however, measure reactivation of the
receptor following desensitization rather than the initial phase of
desensitization examined here. It was technically impossible to examine
the effect of tyrosine phosphorylation on receptor recovery from the
desensitized state because inside-out patches were used, requiring agonist
to be applied in the patch pipette. At the time these experiments were
designed, removal and reapplication of solutions within the patch pipette
on a subsecond time scale was not feasible. Repeated attempts to form
outside-out patches were unsuccessful because of the complex onion-like
structure of the liposomes which precludes the "whole-cell" recording
configuration.
It should be noted that because such recovery experiments could not
be done, the existence of desensitization in the preparation could not be
proven. However it is extremely likely that desensitization, rather than
a non-physiological process that shuts off the channel, is taking place
for three reasons. First, true desensitization of the nAchR is seen in
reconstituted liposomes during flux measurements in which acetylcholine
can be repeatedly washed off and reapplied (Walker et al., 1982). Second,
the concentration dependence of this desensitization is almost identical
to the concentration dependence of the presumed desensitization measured
in these patch clamp experiments. Finally, desensitization of the nAchR
following agonist application has been seen in many electrophysiological
studies of receptors in situ (Boyd, 1987; Feltz et al., 1982; Magleby et
al., 1981).
The increased desensitization rate with tyrosine phosphorylation
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cannot be explained by an indirect effect of tyrosine phosphorylation on
channel density since the desensitization measurement used here is
independent of channel number. Tyrosine phosphorylation of the nAchR or
associated proteins may have such effects on channel clustering or
cytoskeletal interactions: pp60src, the tyrosine-specific protein kinase
product of Rous sarcoma virus prevents nAchR clustering on cultured
chicken muscle fibers (Anthony et al., 1984). Tyrosine phosphorylation
may also play a role in the developmental regulation of the receptor since
innervation during development and denervation of adult muscle regulates
the level of tyrosine phosphorylation (Qu et al., 1990).
The results presented here demonstrate that tyrosine phosphorylation
of the nAchR dramatically increases the rate of the rapid phase of
desensitization. Moreover, dephosphorylation of
phosphotyrosine residues decreases the rate of the
the endogenous
rapid phase of
desensitization to the point where it approaches the rate of the slow
phase of desensitization (Table III). These results suggest that the
rapid phase of desensitization may have an absolute dependence on
phosphorylation. It was not possible to obtain a completely
dephosphorylated preparation of the nAchR by alkaline phosphatase
treatment to test this hypothesis. A completely dephosphorylated
preparation could also address the possibility that phosphorylation is
necessary for receptor activation as has been suggested for the neuronal
nAchR and the GABAA receptors (Margiotta et al., 1987; Stelzer et al.,
1988). If this were the case, one would expect to see a change in channel
number with phosphorylation since a given receptor would be either
dephosphorylated (off) or phosphorylated to a stoichiometry of one (on).
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Site-directed mutagenesis of nAchR prior to expression in oocytes may be
the best way to test the absolute requirement for receptor phosphorylation
for activation or desensitization as well as to determine if all seven
phosphorylation sites are in fact equivalent and additive in their
effects.
This demonstration that tyrosine phosphorylation increases
desensitization is the only existing electrophysiological proof that
phosphorylation of a receptor-gated ion channel alters its channel
properties. The data are consistent with studies on skeletal muscle nAchR
that suggest that agents which raise levels of second messengers and
therefore probably phosphorylate the receptor, modulate receptor
desensitization (Albuquerque et al., 1986; Middleton et al., 1986). This
confirmation that phosphorylation of the receptor increases its
desensitization rate has become important in light of several recent
reports that modulation of nAchR desensitization by forskolin is
independent of cAMP (Wagoner et al., 1988; White, 1988). Concentration
range experiments with forskolin have indicated that it may, at high
concentrations, exert direct anesthetic-like effects on the nAchR
independent of its activation of a second messenger pathway (Middleton et
al., 1988). Phosphorylation of purified receptor-linked ion channels by
identified kinases sacrifices information about intact cell function but
permits analysis of the direct functional consequences of protein
phosphorylation free from such ambiguities of second messenger activation.
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CHAPTER FOUR
D2 Dopamine Receptors in Striatal Neurons are Coupled to a
Potassium Conductance that may be Regulated by Protein Phosphorylation
Striatal neurons are the principal cell type of the caudate-putamen,
a kidney shaped nucleus that is a member of the group of forebrain
structures known collectively as the basal ganglia. Over 95% of striatal
neurons are of one type, medium spiny type II. These GABAergic neurons
receive a large excitatory projection from the cerebral cortex, consisting
primarily of glutamate fibers, and a second afferent proj ection of
dopamine fibers from the substantia nigra, pars compacta (Figure 12).
Branching efferent collaterals proj ect to the globus pallidus and the
substantia nigra as well as to the cell bodies of neighboring medium spiny
neurons (for review, see Gerfen, 1988)
The basal ganglia primarily coordinate sensory and motor signals to
generate programmed and planned movement (Evarts et al., 1984). The
nigro-striatal dopamine pathway appears to be critical in this circuit;
degeneration of dopamine proj ections from the substantia nigra to the
caudate-putamen results in the rigidity and tremor of Parkinson's disease
(German et al., 1989) and the medium spiny neurons of the caudate atrophy
and become aspinous in Huntington's disease (Martin et al., 1986). In
addition, cocaine addiction and major mental pathologies such as
schizophrenia and obsessive-compulsive disorders have been linked to
abnormalities in the basal ganglia and, specifically, to changes in the
dopamine pathways (Seeman, 1987).
Dopamine receptors in mammalian brain can be separated into two
subtypes, D1 and D2, which differ in their anatomical distributions and
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Cerebral cortex Caudatoputamen Substantia nigra
dopamine
GABA
Figure 12 Simplified schematic diagram of the synaptic organization of
the major afferent and efferent connections of the caudate-putamen. The
GABAergic medium spiny neurons, the maj or cell type of the striatum,
receive afferent projections from the cerebral cortex and substantia nigra
and have efferent projections to the substantia nigra. (From Hemmings et
al., 1987)
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pharmacological profiles and mediate distinct behavioral effects (Table
V). The Dl receptor has recently been cloned and has the deduced amino
acid sequence of a G-protein coupled receptor (Dearry et al., 1990). D2
receptors exist in at least two molecular forms in the caudate which are
generated by alternative splicing of a gene that encodes for a seven
transmembrane domain G-protein coupled receptor (Giros et al., 1989).
The electrophysiology of dopamine systems is not well understood.
The dopamine containing neurons that project from the substantia nigra to
striatum have been extensively characterized both in terms of their firing
patterns and their modulation by dendritic dopamine release (for review,
see Grace, 1987). However, the actions of dopamine on target neurons in
the striatum remain ambiguous. Iontophoretic application of dopamine onto
striatal neurons recorded intracellularly has been reported to result in:
depolarization and increased firing (Akaike et al., 1987), depolarization
and decreased firing (Bernardi et al., 1978) and hyperpolarization and
decreased firing (Herrling et aI, 1980). This failure of dopamine to
elicit responses that can be characterized as solely excitatory or
inhibitory has led to the frequent classification of dopamine as a
neuromodulator. Dopamine antagonizes the excitatory effect of glutamate
on striatal neurons (Brown et al., 1983). However, dopamine has also been
reported to enhance both glutamate-induced excitation and GABA-induced
inhibition (Chiodo et al., 1986).
The lack of a consensus on the actions of dopamine in the basal
ganglia has several probable causes. Dopamine binds with similar
affinities to Dl and D2 receptor sub typa s in striatum and therefore








Adenylate Cyclase Coupling Stimulation
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Table V Dl and D2 dopamine receptors in the central nervous system. For
a review of the Dl/D2 classification scheme, see reviews by Anderson et
al., 1990 and Stoof et al., 1984.
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relative inputs among cells and preparations. Dopamine receptors may be
differently coupled to ion channels in dendrites and cell bodies. This
could account for the variation in cell responsiveness seen with the
method of dopamine application; endogenous (dendritic) dopamine
application by stimulation of the substantia nigra generates EPSPs in
striatal neurons whereas exogenous (somatic) dopamine application
decreases the spontaneous activity of cells in the caudate (see for
example, Williams et al., 1990). To further complicate analysis, medium
spiny neurons have recurrent collaterals that synapse onto and rapidly
inhibit neighboring cells making direct versus indirect responses to
dopamine difficult to distinguish (Lighthall et al., 1983).
To examine the signal transduction pathways utilized by Dl and D2
receptors requires an experimental preparation that maximizes the spatial
and temporal resolution of dopamine responses. Striatal slices, the
standard preparation for both physiology and pharmacology, are
synaptically complex and require tedious post-recording dye injection to
identify the recorded cells. Cultured cells, although simple to record
from and easily identifiable, are prone to in vitro developmental
artifacts in their signal transduction mechanisms (Hoch et al., 1989). A
third preparation is acutely dissociated adult neurons which lack synaptic
contacts yet are fully differentiated, morphologically distinct cells.
Dissociated CAl hippocampal neurons have been used to study GABAA and
glutamate receptor interactions (Stelzer et al., 1989).
This chapter presents preliminary data using dissociated neostriatal
neurons to examine the electophysiological correlates of D2 receptor
activation. This work is part of a long term project to determine the
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signal transduction pathways of the striatal Dl and D2 receptors and the





Acutely dissociated neostriatal neurons were prepared from guinea
pig brain in a modification of an isolation procedure developed for
hippocampal neurons (Kay et al., 1986a). For each recording session, one
l20-200g female guinea pig was decapitated, the brain was removed as
rapidly as possible and placed in cold (5°C) PIPES saline containing, in
mM, 120 NaCl, 5 KCl, 1 CaC12, 1 MgC12, 25 D-glucose, 20 PIPES, pH 7.0.
Right and left striata were rapidly dissected out using glass probes and
hand sliced with a platinum razor blade into approx. 500 �m thick coronal
slices. Individual slices were transferred with a fine paintbrush to cold
PIPES saline that had been bubbled with 100% 02.
Once both striata had been cut, the twenty to twenty-five resulting
slices were transferred to a Wheaton Cell-Stir flask containing 15 ml
PIPES saline with 15 mg trypsin added (Sigma type XI, from bovine
pancreas). The time from animal sacrifice to tissue incubation could not
exceed four minutes to retain cell viability. Slices were incubated for
60 to 90 min, at 30°C with continuous 100% 02 bubbling the solution.
Slices were stirred in the flask at a rate sufficient to buoy up the
slices and prevent settling on the bottom but not so rapidly as to
disintegrate the slices or cloud the solution. After incubation, the
trypsin solution was removed and replaced with 15 ml of fresh PIPES
saline. The flask was allowed to come to room temperature while
continuously introducing 100% 02 and stirring the slices. Slices could be
kept alive in this manner for up to six hours post-digestion.
To harvest neurons, two slices were removed from the flask and
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placed in 1 ml of a 2 mM MgC12, calcium-free PIPES saline held in a small
glass vial. The slices were triturated with a series of increasingly fine
fire-polished Pasteur pipettes with inner diameters of 0.5-0.2 mm. The
resulting cell suspension was transferred to a glass bottom recording
chamber and permitted to settle for 5 min. The PIPES saline was replaced
wi th unoxygenated HEPES saline containing, in mM, 140 NaCl, 5 KCl, 1 CaC12,
1 MgC12, 25 D-glucose, 10 HEPES, pH 7.4. Isolated cells, as assessed by
physiology, morphology and trypan blue exclusion, remained viable for at
least one hour post-trituration.
Receptor Binding
To assay the effects of trypsin incubation on dopamine receptors,
parallel incubations of striatal slices were run with and without trypsin
and permitted to recover for 30 min at 20° in fresh PIPES saline. The
slices from both groups were then separately homogenized with a Tissumizer
in 30 ml of a 50 mM Tris-HCl solution, pH 7.4 and centrifuged at 20,000 x
g for 10 min at 4°C. The pellets, after one wash by suspension and
recentrifugation, were resuspended in an incubation buffer containing, in
mM, 120 NaCl, 5 KCl, 2 CaC12, 1 MgC12, 50 Tris-HCl, pH 7.4. Protein
concentrations of the membrane preparation were determined (Bradford,
1976) and the samples were diluted in incubation buffer to final protein
concentrations of 0.05 mg/ml (01) and 0.10 mg/ml (02).
Radioligand binding assays were conducted using either [3H]SCH 23390
to label 01 receptors or [3H]raclopride to label 02 receptors. Following
a 45 min. (01) or 60 min. (02) incubation at 30°C, the samples were
rapidly filtered through Whatman GF/C glass fiber filters, followed by two
53
washes in 5 ml of cold incubation buffer. Radioactivity was determined by
liquid scintillation spectrophotometry. Specific binding was defined to
be the total binding minus the nonspecific counts in control samples
incubated with both the radioligand and a competitive receptor subtype-
specific non-radiolabelled ligand (30 J.£M SKF 38393 for Dl and 300 J.£M
sulpiride for D2). Saturation binding parameters of [3H]SCH 23390 and
[3H]raclopride were determined by Scatchard analysis.
Patch Clamp Recording
Patch-clamp electrodes were pulled in two stages on a Kopf 720
vertical puller and fire-polished to a final resistance of 2 to 4 Mohm
with a Narishige microforge. Electrodes were back-filled with one of the
following solutions (in mM):
Potassium Fluoride: 120 KF, 1 CaC12, 1 MgC12, 11 EGTA, 10 HEPES, pH 7.4
Potassium Methanesulfonate: 100 KMeS03, 30 KGl, 4 MgC12, 2 ATP, 10 EGTA,
10 HEPES, 0.1 leupeptin (a thiol-protease
inhibitor), pH 7.4
All dopaminergic drugs were dissolved in HEPES saline and either bath
applied or picospritzed onto isolated cells. Solutions containing
dopamine included 250 J.£M ascorbate to slow oxidation and were kept on ice.
For the experiments with kinase injection, catalytic subunit of cAMP-
dependent protein kinase was purified from bovine heart (Kaczmarek et al. ,
1980) and added to potassium methanesulfonate electrode solutions (final
concentration 12 J.£g/ml (300 nM». HEPES saline was used as the bath
solution for all recordings and in some experiments, as noted in the text,
was supplemented with blocking agents.
Dissociated cells were observed with a Zeiss IM-35 inverted
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microscope equipped with phase contrast and differential interference
contrast (Nomarski) optics. Voltage clamping in the whole cell
configuration was conducted using a patch clamp system, similar to that
described by Hamill et al., 1981a, consisting of an Axopatch lA amplifier,
Narishige hydraulic micromanipulator and TL-l DMA interface (Axon
Instruments). Pipette capacitance and series resistance were
electronically compensated. Current records were sampled at 200 to 10,000
Hz and filtered appropriately (-3dB, 8 pole Bessel filter). Data were
sampled, stored and analyzed using Pclamp versions 4.0-5.1 (Axon




Healthy isolated cells, viewed under phase contrast microscopy, had
uniformly bright cell bodies and retained proximal dendrites. Medium
spiny neurons preserved their characteristic morphology displayed in
Golgi-stained preparations consisting of a 10-15 �m pyramidally-shaped
cell body and branched apical dendrites (Figure 13a). Medium spiny
neurons were readily distinguishable from glia which tended to remain in
large sheets, and from minor subpopulations of other cells such as the
large aspiny cholinergic neurons which differed dramatically in size and
dendritic morphology (Figure 13b). The existence of smooth somatic
surfaces when viewed under Nomarski optics was a good indicator of
neuronal vitality. As cells were perfused and began to "run-down" during
whole cell recording, cells developed grainy plasma membrane textures and
nuclei could be observed (Figure l3c).
Trypsin digestion has been reported to alter membrane-bound proteins
(Lee et al., 1977). To investigate if 01 or 02 receptors were damaged by
the dissociation procedure, dopamine receptors were labelled with the 01
antagonist [3H]SCH 23390 or the 02 antagonist [3H]raclopride from slices
that had been incubated with and without trypsin. Saturation curves of
specific radioligand binding to the receptors and Scatchard analyses were
used to obtain binding parameters of dopaminergic compounds to the treated
and non-treated receptors (Table VI). The only statistically significant
change in binding with trypsin treatment was a 50% decrease in the number
of 01 binding sites (B�x). The affinity (�) of SCH 23390 for the 01
receptor and both the affinity and number of 02 receptors as assayed by
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Figure 13 Photomicrographs of dissociated neostriatum. A: Medium spiny
neurons, marked with arrows, under phase contrast. The cells retain their
characteristic somatic shape and branching proximal dendrites. B: A
large cholinergic aspiny neuron viewed with Nomarski optics. Such non­
dopamine receptor containing neurons comprise less than 5% of the
identifiable dissociated cells. C: A medium spiny neuron after 10 min.
of whole-cell patch clamp recording. As the cell "runs down", cellular
organelles become visible. Inclusion of the protease inhibitor leupeptin
in the patch pipette prevents the processes from retracting during
recording. Scale bar= 20 �m
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Before Cold Shock After Cold Shock
Bmax (fmol/mg protein) Ko(nM)
control 1931±326 (6) 0.45±0.10 (6)
Dl trypsin 1094±368 (5) 0.73±0.31 (6)
control 477±102 (5) 7. 82±1. 08 (5)
D2 trypsin 39l±89 (3) 6.l3±3.08 (3)
Table VI Saturation binding parameters of [H3] SCH 23390 and [H3] raclopride
to Dl and D2 receptors in control- and trypsin-treated guinea pig striatal
slices. The lower Bmax of Dl receptors in trypsin-treated cells compared
to non-trypsin-treated controls was the only binding parameter that
significantly changed with enzymatic digestion (p<0.05). Data are
expressed as means ± standard deviations and were compared using Student
t-tests. These results indicate that guinea pig dopamine receptor binding
parameters differ from those of other mammalian species previously
examined: the Dl receptors are five fold lower in affinity than those in
rat striatum (Faedda et al., 1989) and the D2 receptors are ten fold lower
in affinity that those in rat and rabbit (Dewar et al., 1989). Whether
these differences reflect true species variations or merely differences in
the method of tissue preparation remains to be determined.
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raclopride binding were unchanged.
Isolated medium spiny neurons (n - 76) had mean resting potentials
of -59 mV (range, -75 to -47 mV) and mean input resistances of 600 Mohm
(range, 300 to 1100 Mohm). They could be held for up to twenty minutes in
the whole-cell voltage clamp configuration with longevity being determined
both by individual cell health and the choice of intracellular dialysis
solution. Inclusion of ATP and Mg* in the patch pipette delayed "run
down" as did the use of potassium fluoride as the dominant ionic species.
During recording, spontaneous firing of action potentials was rare, as has
been reported in striatal slices and the caudates of awake behaving
animals (Calabresi et al., 1990).
Whole-cell voltage clamp current recordings indicated that the cells
remained electrically excitable after dissociation. Cells in HEPES saline
that were recorded from with potassium fluoride-containing electrodes
could be held at -90 mV. Step depolarizations for 75 msec to voltages up
to +30 mV resulted in fast inward and delayed outward currents (Figure
14). The voltage-activated outward current (Figure l5a) had a mean peak
amplitude at +40 mV of 2.2 nA (range, 400 pA to 5.3 nA) with a threshold
of -50 to -70 mV. No inactivation was observed during voltage steps as
long as 250 msec. This outward current could be abolished by bath
application of 20 mM TEA (data not shown). The voltage-activated inward
current (Figure l5b) had a mean peak amplitude of 4.1 nA (range, 750 pA to
14 nA) with a threshold of -40 to -50 mV. This current rapidly
inactivated within 10 msec of voltage application and was TTX sensitive
(5j.£M).







Figure 14 Voltage-activated currents recorded from a cell in the whole­
cell patch clamp configuration. Ionic currents were elicited by voltage
steps from -90 mV to +30 mV in 10 mV increments from a prepulse potential





Figure 15 Current-voltage plots of peak current versus membrane
potential for the cell shown in Figure 14. A: Peak outward current during
the 75 rnsec voltage step application. B: Peak inward current during the
75 msec voltage step application.
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internal solutions were used. Although potassium fluoride-containing
electrodes promoted long-lived whole cell clamping, fluoride has been
reported to alter the kinetic parameters of calcium currents (Kay et al. ,
1986b). Dopamine application to isolated striatal neurons elicited two
types of responses. In cells that were poorly space clamped, 10 JLM
picospritzed dopamine evoked repetitive action potentials when neurons
were sampled in HEPES saline without channel blockers (Figure l6a). More
frequently, bath application of dopamine elicited a complex, non-spiking,
response in 12 out of 19 cells sampled. This consisted of an increase in
basal conductance that could be reversed by washing the recorded cell with
HEPES saline (Figure l6b).
To investigate the role of dopamine receptor SUbtypes in mediating
cell responsiveness, it was necessary to prevent the activation of non­
agonist specific conductances. Highly selective D2 receptor agonists were
therefore applied to cells in a 20 mM TEA, 5 JLM TTX-containing HEPES
saline. The D2-selective agonist, quinpirole, enhanced a time-dependent
outward conductance in 7 of 13 cells sampled (Figure l7a). The size of
this conductance increase at +30 mV ranged from 100 to 400 pA and was
dependent on the concentration of agonist; higher doses of quinpirole
elicited larger outward currents (Figure l7b). This outward conductance
could also be evoked by bathing cells in dopamine coapplied with the DI
antagonist SCH 23390, further suggesting that the conductance is D2-
specific (Figure 18). The size of the outward current increased with time
after drug application, appearing within seconds of drug application and
reaching a peak wi thin 60 seconds. The conductance could not be evoked by






















Figure 16 Membrane currents elicited by dopamine application. A: The
neuron was held at -60 mV and step depolarized for 800 msec to -30 mV
simultaneous with picospritzer-application of either HEPES saline
(control) or 10 pM dopamine. B: A different neuron bathed in 5 pM TTX to
block action potentials and step depolarized in 10 mV increments from a
holding potential of -60 mV up to +30 mV. Bath application of 10 pM
dopamine elicited a change in voltage-dependent currents that could be
abolished by washing the recorded cell with HEPES saline.
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Figure 17 The D2-selective agonist quinpirole enhances an outward
conductance. A: Step-depolarizing pulses of -90 to +30 mV in 20 mV
increments from a holding potential of -60 mV. Control=HEPES saline bath
solution containing TEA and TTX, Quin=HEPES plus 10 �M quinpirole bath
solution. B: Current responses of a different cell picospri tzed in
succession with HEPES, 10 �M quinpirole and 50 �M quinpirole when
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Figure 18 Current-voltage plot of peak outward current versus membrane
potential of the D2-specific conductance in the presence of various
dopaminergic agents. Data are from one cell which was bathed sequentially
in HEPES (control), HEPES plus 50 pM SKF 38393 (Dl agonist), HEPES plus 10
pM dopamine and 50 pM SCH 23390 (Dl antagonist) sampled 30 and 60 seconds
post-application. The potassium equilibrium potential in these
experiments is approximately -80 mV.
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the 01 agonist SKF 38393.
To investigate the role of protein phosphorylation in mediating this
02 response, cells were bathed in the potent adenylate cyclase activator
forskolin, following whole-cell patch clamp and 02 agonist application.
In 3 out of 4 cells examined, forskolin elicited a time-dependent
reduction in the outward current evoked by bath application of 10 J.LM
quinpirole (Figure 19a). This reduction in current was maximal within two
minutes and did not recover with washing of the recorded cell and
reapplication of agonist.
Although the majority of the experiments were conducted using whole­
cell patch clamping, high resistance cell attached seals were occasionally
formed. In three such cases, bath application of quinpirole elicited
voltage-dependent channel activity within the isolated membrane patch
which was not itself exposed to agonist (Figure 19b). This suggests that
a second messenger system couples the 02 receptors to their associated
channels. Forskolin, applied to the bath during one such cell-attached
patch recording, resulted in closure of the quinpirole-activated channels
(Figure 19b). Since the forskolin was applied to membrane surfaces
isolated from the membrane sampled in the patch pipette, the decrease in
channel activity is likely to stem from a second messenger-mediated effect
rather than an anesthetic-like block of the channels. It is possible that
forskolin may diffuse in the plane of the membrane into the patch.
Experiments with non-adenylate cyclase activating forskolin analogues can
address this question.
Forskolin stimulation of adenylate cyclase leads to the formation of










Figure 19 Forskolin inhibits quinpirole-activated conductances. A: Step
depolarizations from a membrane holding potential of -60 mV up to +30 mV
elici t currents when the cell is picospri tzed with 10 pM quinpirole.
Following bath application of 10 pM forskolin (0 s), the size of this
evoked current diminishes over time (30 and 75 s) B: Single channel
recording of outward current conducting channels from a cell-attached
membrane patch held at +30 mV to generate a 90 mV potential across the
membrane. The 4 pA channel events are not seen in the absence of agonist
(control) and are elicited by bath application of 50 pM quinpirole.
Agonist-induced channel events are irreversibly blocked by the addition of
10 JlM forskolin to the bath.
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kinase was involved in the second messenger mediated inhibition of
dopamine-evoked currents, cells were perfused with the catalytic subunit
of cAMP-dependent protein kinase. In two out of two cells recorded from
with 300 nM of catalytic subunit in the patch pipette, no outward currents
were elicited by D2 receptor stimulation (data not shown). Although such
preliminary data lends support to the idea that phosphorylation of an
unidentified molecule inhibits the D2 receptor to channel pathway, it must
be noted that cells dialyzed with catalytic subunit had suppressed basal,
time-independent, conductances as well. The kinase may therefore be
having non-selective effects on cell excitability. Control experiments
with heat-inactivated catalytic subunit are planned.
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DISCUSSION
The results suggest that D2 receptor stimulation in guinea pig
neostriatal neurons induces a transient outward potassium conductance at
membrane potentials positive to -60 mV. Dopamine stimulation of a
voltage-dependent transient outward current has been observed in clonal
pituitary cells that express D2 receptors (Login et al., 1990). In rat
striatum, dopamine application has been reported to open an 85 pS
potassium channel that may be D2-specific (Freedman, 1988). This large
channel, which has the unusual pharmacological property of blockade with
nanomolar concentrations of quinine (Freedman, 1989), is probably distinct
from the current described here whose single channel conductance is in the
35 to 45 pS range.
The increase in outward conductance has at least two temporally
distinct components that may reflect different signal transduction
mechanisms. The initial increase in outward conductance occurs within
seconds of agonist application (Figure 17) which may reflect direct G­
protein gating of a channel. This outward conductance increases over the
next minute of recording (Figure 18). This slower coupling mechanism
could be due to the down regulation of cAMP-dependent protein kinase
activity and the subsequent dephosphorylation of a substrate by active
protein phosphatases.
One intriguing possibility is that the voltage-dependent outward
current observed here is lA' a transient potassium conductance present in
most excitable cells. This current differs from the delayed outward
current of Hodgkin and Huxley (lK) in its activation at relatively
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hyperpolarized values (threshold, -45 to -60 mV), rapid inactivation and
selective block with 4-aminopyridine (Rogawski, 1985). Although
experiments varying potassium concentration have not yet been conducted on
these striatal neurons, the current's insensitivity to TEA and its voltage
sensitivity suggest that it may be IA. The current is unlikely to be a
calcium or calcium-dependent potassium conductance because the patch
pipette contained high levels of EGTA to chelate intracellular calcium.
IA has been demonstrated to be modified by protein phosphorylation in
several systems. The reduction of IA in Hermissenda photoreceptors with
associative learning can be mimicked with intracellular injection of
calcium/calmodulin-dependent protein kinase (Farley et al., 1985). IA in
Aplysia bag cells is similarly reduced in amplitude by the application of
forskolin (Strong, 1984).
Muscarinic acetylcholine receptors in neostriatal neurons have been
shown to increase the peak conductance of IA and shift its voltage
dependence towards more negative membrane potentials (Akins et al., 1990).
The 02 dopamine receptor and the muscarinic receptor may therefore be
coupled to the same conductance in neostriatal neurons. Such a
convergence of multiple receptors onto the same channel has a precedence
in the literature: GABAA and serotonin receptors are coupled to a common
potassium channel in hippocampal pyramidal cells (Andrade et al., 1986).
Indirect evidence suggests that 02 and GABAs receptors may share a
potassium conductance in substantia nigra neurons (Lacey et al., 1988).
This postulated convergence of 02 and muscarinic receptors of
striatal neurons onto a common potassium conductance is an attractive
hypothesis because protein phosphorylation has been implicated in the
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desensitization of muscarinic responses. Under basal conditions, M2
muscarinic acetylcholine receptors increase potassium conductances in
heart and central neurons through an intervening G-protein. This appears
to be a direct coupling mechanism independent of a second messenger
cytoplasmic pathway although the precise GK protein subunit that mediates
the response (a versus P�) is unresolved (Logothetis et al., 1987; Yatani
et al., 1988) . Protein phosphorylation-inducing agents mimic the
desensitization of the muscarinic receptor responses, suggesting that
phosphorylation of the receptor or its associated G-protein uncouples
their interaction (Kwatra et al., 1987). In the experiments described
here, protein phosphorylation may also be uncoupling the D2 receptor to
channel connection by phosphorylating the receptor, the channel or a
regulatory molecule (e.g. a G-protein).
Dopamine's D2 receptor mediated action on striatal neurons described
here is similar to dopamine's activation of potassium conductances in
other mammalian central neurons. Dopaminergic inhibitory postsynaptic
potentials are mediated by an increased potassium conductance, although
not lA, in both substantia nigra and pituitary (Lacey et al., 1987;
Williams et al., 1989). Invertebrate neurons, however, have dopamine
receptors that are differently coupled. In Helix, dopamine decreases a
voltage-dependent calcium current via a molluscan G-protein that is
immunologically related to Go (Harris-Warrick et al., 1988).
The data presented here are initial steps towards defining the D2
signal transduction pathway in neostriatal neurons. Definitive
identification of the D2-coupled conductance, determination of whether the
response is G-protein mediated and the molecular dissection of the role of
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protein phosphorylation in mediating this response remain to be done. The
preparation of acutely dissociated striatal neurons developed for this
project is ideal for whole-cell patch clamp experiments because the cells
have clean surface membranes, aiding seal formation, and lack distal
dendritic processes, reducing space clamp problems. There is, however,
the possibility that trypsin digestion may irreversibly alter membrane
inserted channels or receptors. Receptor binding assays indicated that
although the D2 receptors on the striatal neurons were unaffected by the
trypsin treatment, Dl receptor binding sites were halved in number. For
this reason, Dl-specific conductances were not examined in these
experiments. A better system for examining the Dl signal transduction
pathway may be the NS20Y neuroblastoma cell line which contains high
levels of Dl receptors that are positively coupled to adenylate cyclase
(Barton et al., 1989).
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CHAPTER 5
Dopamine Inhibits Na+,K+-ATPase Activity in Striatal Neurons
through 01 and 02 Receptor Synergism
Na+,K+-ATPase, an integral membrane protein located in virtually all
animal cells, couples the hydrolysis of ATP to the counter-transport of Na+
and K+ ions across the plasma membrane (Skou, 1965). The enzyme consists
of an oP heterodimer. The ° subunit, a 112 kDa protein with six to eight
transmembrane domains, contains the binding sites for Na+, K+, and ATP and
exists in three genetically distinct isozymes, 01' 02 and 03 (Shull et al.,
1986). The p subunit, a 40-60 kOa glycoprotein that may regulate
transport and insertion of the catalytic subunit, has at least two enzyme
forms, P1 and P2 (Young et al., 1987). The Na+,K+-ATPase is a member of
the family of P-type ATPases that includes the Ca++-ATPases of plasma
membrane and sarcoplasmic reticulum, the gastric H+,K+-ATPase and H+ pumps
in yeast and bacteria. Activity of these pumps is associated with
phosphorylation and dephosphorylation of the active site of the catalytic
subunit and E1-E2 conformational transitions (Blostein, 1989).
Na+,K+-ATPase activity controls either directly or indirectly many
essential cell functions (for review, see Rossier et al., 1987). The
transmembrane electrochemical potential gradient for Na+ ions generated by
the ATPase drives the transport of amino acids, sugars, and Ca++, Cl- and
H+ ions across the membrane. The ATPase maintains osmotic stability and
therefore cell volume as well as the high intracellular K+ levels needed
for many enzymes. ATPase activity also generates heat, accounting for
more than 20% of the basal metabolic rate of adult mammals.
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In neurons and other excitable tissues, the enzyme maintains the
transmembrane ionic gradients that underlie resting and action potentials
and permit active uptake of nutrients and neurotransmitters. Na+,K+-ATPase
activity in such excitable tissues critically influences electrical
activity. Each pump cycle of 3 Na+ out/2 K+ in generates a net extrusion
of positive charge and hence an outward current that contributes to the
cell membrane potential. The enzyme also indirectly regulates electrical
excitability by maintaining the ionic gradients for Na+ and K+ that are
continually dissipated by ionic fluxes across the cell membrane.
It is tempting, given the critical role the Na+,K+-ATPase plays in
electrical excitability, to hypothesize that the enzyme is regulated as a
form of neuromodulation. Na+,K+-ATPase activity can be directly regulated
by monovalent cations (particularly intracellular Na+ and extracellular K+
ions), ATP and cardiac glycosides (Glynn, 1985). These endogenous
regulators have been implicated in such physiological processes as renal
sodium excretion, heart failure, insulin responsiveness and hypertension
(Hamlyn et al., 1984). However, modulation of the enzyme by a
neurotransmitter has only been convincingly demonstrated in the kidney,
where dopamine and epinephrine inhibit pump activity (Aperia et al., 1987;
Beach et al., 1987). This regulation requires an intact cell system;
dopamine has no effect on the activity of purified enzyme from rat kidney.
This suggests that dopamine stimulation activates intracellular second or
third messengers that themselves regulate the ATPase activity.
Neostriatal neurons in the basal ganglia contain both Dl and D2
dopamine receptors (see Chapter 4). To examine if activation of dopamine
receptors in brain modulates pump activity, dissociated neostriatal
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neurons were incubated with dopaminergic drugs and Na+,K+-ATPase activity




Acutely dissociated striatal neurons from guinea pig brain were
prepared by trypsin digestion of striatal slices as described in Chapter
4. Following the incubation with trypsin, the slices were allowed to
recover for 30 min at 22°C in fresh PIPES saline. The slices were then
triturated in 1 ml of calcium-free, 2 mM magnesium, PIPES saline with a
series of increasingly fine-bore pasteur pipettes to disperse the neurons.
The resulting milky suspension was allowed to settle for 15 sec to permit
sedimentation of undissociated neuropil and fiber tracts.
Na+,K+-ATPase activity
Na+ ,K+-ATPase activity was measured by a procedure modified from that
developed for isolated kidney cells (Bertorello et al., 1989).
Preincubation for a variable period at 22°C was started by transferring 45
J.£l aliquots of the cell suspension to HEPES saline containing either
dopaminergic drugs or vehicle (final volume 100 J.£l). The preincubation
period was stopped after 1 to 15 min. by rapid cooling to 4°C. 10 J.£l
aliquots of the cell suspension (2-7 J.£g protein) were transferred to the
Na+,K+-ATPase assay medium (final volume 100 J.£l) containing, in mM, NaCl
50, KCl 5, MgC12 10, EGTA 1, Tris-HCl 100 and 32P-Na2ATP 10 (sp.act. 3000
Ci/mmol). Cells were transiently permeabilized by placing the samples at
-20°C for 10 min to permit the entry of 32p-ATP and stabilize the
intracellular Na+ concentration at 70 mM (50 mM NaCl and 10 mM 32P-Na2ATP) .
Cells did not freeze during this procedure and they maintained their
morphology (see Figure 20). Samples were then incubated at 37°C for 15
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min. The reaction was stopped by rapid cooling to 4°C and TCA/charcoal
(5%/10%) was added immediately to bind free ATP. Na+,K+-ATPase activity,
measured by liquid scintillation spectrophotometric counting of the
liberated 32p, was calculated as the difference between the averages of
duplicate test samples (total ATPase activity) and duplicate samples
assayed in a Na+- and K+-free solution containing lmM ouabain (ouabain-
insensitive ATPase activity).
Bradford (1976).
Protein was measured by the method of
Dopamine Depletion
For the experiments using dopamine-depleted tissue to investigate Dl
and D2 receptor synergism, guinea pigs were anesthetized with
methoxyflurane and tube fed 300 mg benserazide chloride per kg bodyweight
using 1 ml water as vehicle, one hour prior to sacrifice. The cell
dissociation and Na+, K+-ATPase assay were run as described above. The
extent of dopamine depletion in the intact slices or triturated cell
suspensions was measured in a separate series of experiments using trypsin
digested striata from dopamine-depleted animals. Tissue samples were
homogenized in 0.4M perchloric acid (PCA), and the dopamine was adsorbed
onto alumina at pH 8.6 and eluted in 0.1 M PCA. Dopamine in the eluate
was analyzed by reverse-phase HPLC with electrochemical detection using a
BAS LC-4B detector and a BAS PM-48 pump (Sharp et al., 1986). Protein was
analyzed by the procedure of Lowry et al (1951).
Western blotting
Three right and left guinea pig striata were dissected, frozen in
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liquid nitrogen and kept at -70°C until analysis. Tissue pieces were
homogenized by sonication in 1 ml 1% (wt/vol) boiling SDS and maintained
in a boiling water bath for 10 min. Protein concentrations were
determined by the procedure of Lowry et al., (1951). Aliquots of this
homogenate (5-75 pg protein/lane) were subjected to SDS/PAGE (15%
acrylamide) and electrophoretically transferred to nitrocellulose
membranes (0.2 pM pore size) at pH 8.9 (Towbin et al., 1979). Protein
aliquots for the detection of the phosphoprotein ARPP-2l were transferred
using modified conditions of a 50 mM MES buffer at pH 5.5 with 20%(v/v)
methanol and 0.025 pM nitrocellulose. Nitrocellulose membranes were
blocked in a solution containing 5% milk and 0.1% TWEEN 20 in phosphate
buffered saline (PBS) for 30 min. The membranes were then incubated for
2 hrs. in 15 ml of blocking solution containing one of three antibodies:
a rabbit antiserum against both ARPP-16 and ARPP-19 (antisera number G153,
1:500 dilution), a mouse monoclonal antibody directed against DARPP-32
(antibody number C24-6A, 1:1000 dilution) or a mouse monoclonal antibody
directed against ARPP-2l (antibody number 2l-6A, 1:1000 dilution). After
rinsing in PBS (3 x 5 min.), nitrocellulose membranes that had been probed
with mouse monoclonal antibodies were then incubated serially in blocking
solution containing rabbit anti-mouse antibody (1:500 dilution) for 1 hr.,
then in 125Iodine-protein A (1:1000 dilution) for two hrs., whereas those
membranes probed with rabbit antisera (G153) were directly incubated in
125I-protein A for 2 hrs. Nitrocellulose membranes were then dried and




To investigate the presence of basal ganglia-specific
phosphoproteins, a 260g female guinea pig was anesthetized with chloral
hydrate (400 mgjkg) and perfused transcardially with 4% paraformaldehyde
in a 0.1 M sodium phosphate buffer. 50 JJm thick coronal slices of
striatum were incubated in a 1: 30,000 dilution of a mixture of three
murine monoclonal antibodies against DARPP-32 (Ouimet et al., 1984). The
tissue was processed for immunocytochemistry using an avidin-biotin
complex method with biotinylated goat anti-mouse IgG as the secondary
antibody (Gustafson et al., 1990). Antibodies were visualized with 3,3'-
diaminobenzidine and hydrogen peroxide treatment. The sections were




Na+,K+-ATPase activity was assayed as ouabain-sensitive ATP
hydrolysis in a cell suspension of acutely dissociated striatal neurons
from guinea pig. Dissociated striatum yields a cell population which,
morphologically, is nearly homogeneous: an estimated 95% of striatal
neurons are of a single type, namely medium spiny type I (Gerfen, 1988),
and almost all astrocytes and myelinated fibers settle out of the cell
suspension. Isolated cells retained their characteristic medium spiny
morphology and proximal dendritic structure and displayed voltage- and
neurotransmitter-coupled ionic conductances (see Chapter 4).
To measure pump activity, intact cells were preincubated with
dopaminergic drugs and then permeabilized by cold shock to load cells with
32p-ATP and stabilize the intracellular Na+ concentration at 70 mM. This
cold shock procedure did not significantly dis�upt the morphology of the
isolated cells which retained their dendritic structures and somatic shape
(Figure 20). Cell membranes maintained their integrity both before and
after the permeabilization procedure; no detectable 32p was liberated when
cells were incubated with 32p-ATP without prior cold shock and following
permeabilization, cells did not leak 32p into the surrounding media.
Na+,K+-ATPase activity in control samples averaged 199±13 nmol Pi/mg
protein/min (n=19). Ouabain insensitive ATP hydrolysis (Mg++-ATPase
activity) averaged 209±14 nmol Pi/mg protein/min (n=19) and accounted for
approximately half of the total ATPase activity as has been described in
other tissues and species (Katz et al., 1979). This ouabain-insensitive
component of ATPase activity was unaffected by any of the experimental treatments.
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Figure 20 Photomicrographs of dissociated medium spiny neurons viewed
under Nomarski optics. Left: isolated cell after 10 min incubation with
dopamine and before cold shock. Right: a different cell from the same
experiment after incubation with dopamine and subsequent permeabilization
by cold shock. Scale bar - 15 �m.
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Incubation of the cell suspension with dopamine inhibited Na+,K+-
ATPase activity in a concentration dependent manner (Figure 21). lnM
dopamine was sufficient to induce significant inhibition of the enzyme
activity to 76% of control level. The maximal effect, 50% inhibition, was
obtained at dopamine concentrations of 10 �M.
This inhibition developed over time following an initial lag of 2 to
3 minutes (Figure 22). The inhibitory effect was maximal within 5 minutes
of dopamine application and persisted for at least another 10 minutes.
This decrease in enzyme activity over time did not represent a rundown of
the striatal neurons; control samples without added dopamine at 1 and 15
minute incubation intervals had mean Na+,K+-ATPase activities of 230±17
(n=3) and 20l±23 (n=4) nmol/mg protein/min respectively.
To investigate the pharmacology of this inhibition, cells were
incubated with dopamine in the absence or presence either of the selective
Dl antagonist SCH 23390 or of one of the selective D2 antagonists, YM-
09151 or S-sulpiride (Figure 23). Addition of either a Dl or D2 specific
antagonist (10 �M) to the cell suspension was sufficient to prevent
dopamine (1 �M)-induced inhibition of Na+,K+-ATPase activity and maintain
enzyme activity at control levels. The antagonists might have been
expected to, but did not, raise the enzyme activity to above control
levels by blocking the inhibitory effect of endogenous dopamine.
Stimulation of the ATPase may not have been kinetically possible under the
assay conditions of 70 mM Na+ which is close to the Vmax for the enzyme.
To examine the contributions of Dl and D2 dopamine receptor subtypes
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Figure 21 Concentration dependence of dopamine inhibition of Na+ ,K+-ATPase
activity. Cells were incubated for 10 min with the indicated
concentrations of dopamine and compared with control samples incubated
without dopamine for 10 min (mean activity 206±15 nrnol Pi/mg
protein/min, n=28). Data represent means ± s.e.m. of 3-7 experiments. No
change in enzyme activity was observed in samples of control cells
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Figure 22 Time dependence of dopamine inhibition of Na+, K+-ATPase
activity. Cells were incubated with 1 J.LM dopamine for the indicated
periods of time and compared with control samples incubated without
dopamine (mean activity = 206±15 nrnol Pi/mg protein/min, n=28). Data
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Figure 23 D1 and D2 antagonists each prevent the inhibitory action of 1
�M dopamine. SCH = 10 �M of the D1 antagonist SCH 23390, YM = 10 �M of
the D2 antagonist YM-091S1, SS= 10 �M of the D2 antagonist S-sulpiride.
Results represent means ± s.e.m. of 4 experiments. For each antagonist,
data represent enzyme activity in the presence of dopamine expressed as
percentage of that observed in the absence of dopamine (mean activity =
147±11 nmol Pi/mg protein/min, n=14). * P<O.OOS compared to control (no
dopamine) and compared to dopamine plus dopamine antagonists. (From
Bertorel1o et a1., 1990)
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activation of receptors by endogenous dopamine. For this purpose, animals
were pretreated with the L amino acid dopa decarboxylase inhibitor,
benserazide, to deplete endogenous dopamine stores (Da Prada et al.,
1984). This drug has been used to deplete dopamine stores in renal tissue
prior to ATPase activity measurements and has no known effect on pump
activity or number (Bertorello et al., 1988a). Benserazide treatment
reduced the dopamine concentrations by two to three fold both in striatal
slices and in triturated single cell suspensions from such slices compared
to vehicle treated controls (Table VII).
In such benserazide-treated animals, neither 100 nM of the 01
selective agonist SKF 82526 nor 100 nM of the 02 selective agonist LY
171555 was itself sufficient to produce significant inhibition of Na+,K+­
ATPase activity (Figure 24). However, addition of 100 nM SKF 82526 with
100 nM LY 171555 resulted in an inhibition to about one-half of control
level, indicating that both receptor sUbtypes must be activated to induce
enzyme inhibition. This synergistic effect of 01 and 02 receptor co-
activation was not a reflection of higher total agonist concentration in
the agonist mixture: 1 �M doses of SKF 82525 and LY 171555 presented alone
resulted in Na+,K+-ATPase activity of 104±38% (n=4) and 90±10% (n=2) of
control values respectively.
In vehicle-treated animals that did not receive benserazide (n=3),
100 nM SKF 82526 and 100 nM LY 171555 each given alone reduced Na+,K+­
ATPase activity to 78 and 70% of control levels, respectively (Figure 24).
The two agonists, when present together, reduced enzyme activity to 65% of
control. This ability of either selective agonist alone to inhibit Na+,K+­
ATPase activity suggests that endogenous dopamine in the cell suspension,
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Table VII Striatal dopamine levels of benserazide and vehicle-treated
animals as measured by HPLC. Striatal slices were trypsin digested and
then either left intact or triturated into a dissociated cell suspension
before homogenization and subsequent dopamine adsorption. Data represent
































Dl D2 Dl+D2 Dl D2 Dl+D2
Figure 24 Synergistic action of Dl and D2 agonists as inhibitors of
Na+,K+-ATPase activity. Animals had been pretreated with benserazide to
deplete endogenous dopamine or control treated with vehicle. Dl - 100 nM
of the Dl agonist SKF 82526, D2 - 100 nM of the D2 agonist LY 171555.
Resul ts represent means ± s. e. m. of 3 to 4 experiments. In each
experiment, results were calculated as percentage of a non-agonist treated
control. * - P<O. 005 compared to control and compared to Dl and D2
agonists alone. (Adapted from Bertorello et al., 1990)
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released during mechanical trituration of the slices, may have caused some
activation of both receptor subtypes. In support of this interpretation,
basal enzyme activity in samples from vehicle-treated animals was slightly
lower (154±22 nmol Pi/mg protein/min,n=3) than in samples from
benserazide-treated animals (179±10 nmol Pi/mg protein/min,n=4), possibly
reflecting tonic inhibition of enzyme activity by endogenous dopamine in
the cell suspensions.
01 receptor activation in striatum stimulates adenylate cyclase
leading to the formation of cAMP and the activation of cAMP-dependent
protein kinase (Kebabian et al., 1972; Hemmings et al., 1987).
Experiments with the potent adenylate cyclase activator forskolin suggest
that this second messenger pathway and protein phosphorylation underlie
the receptor interaction observed here. 10 �M forskolin, when co-applied
with 100 nM of the 02 agonist LY 17155, produced a synergistic reduction
of Na+,K+-ATPase activity to 50% of control (Figure 25). Forskolin or LY
17155 applied alone reduced enzyme activity nonsignificantly to 81% and
91% of control levels.
02 receptor activation has been linked to the polyphosphoinositol/
diacylglycerol pathway and activation of protein kinase C. A ten minute
incubation with 1 �M PMA mimicked the effect of dopamine by inducing
inhibition to 42% of control levels (28l±35 nmol Pi/mg protein/min, n=4).
This PMA effect on enzyme activity required an unusually high dose of the
phobol ester and did not require 01 receptor activation, suggesting that
it may be acting through a non-02 selective pathway. No change in ATPase
activity was seen with the nanomolar concentrations of PMA that are






























Figure 25 Forskolin m1m1CS Dl receptor activation. FSK - 10 JJM
forskolin, 02 - 100 nM of the 02 antagonist YM-09l5l. Results represent
means ± sem of 3 experiments. For each drug application, data represent
enzyme activity expressed as a percentage of non-treated control with mean
activity of 106 ± 30 nmol Pi/mg protein/min. *-p<0.005 compared to
control and compared to forskolin and 02 antagonist alone.
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As an initial step towards defining the role of protein
phosphorylation in the Na+,K+-ATPase inhibition, guinea pig striata were
screened for the existence of adenylate cyclase-regulated phosphoproteins.
Antibodies raised in mouse or rabbit against four basal ganglia specific
phosphoproteins, ARPP-16, ARPP-19, ARPP-21 and DARPP-32 were used to probe
guinea pig striatal homogenates by standard immunoblotting procedures
(Figure 26). All four of these phosphoproteins were found at high levels.
One of these phosphoproteins, DARPP-32, is known in other mammalian
species to be selectively localized to cells containing D1 receptors
(Hemmings et al., 1987). Immunocytochemistry of guinea pig striatal
slices with monoclonal antibodies to DARPP-32 revealed that the medium
spiny neurons used in the Na+,K+-ATPase assay have high levels of this
protein (Figure 27).
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Figure 26 Autoradiogram of western blots of guinea pig striatal
homogenates probed for the basal ganglia enriched phosphoproteins, ARPP-
16, ARPP-19, ARPP-21 and DARPP-32. 75 �g of protein was loaded per lane.
The additional bands in the DARPP-32 lane probably represent degradative













Figure 27 Photomicrograph of immunoreactive DARPP-32 containing neurons
in guinea pig striatum. The cell bodies and processes of the medium spiny
neurons are heavily stained. The surrounding white matter of corticofugal




A large and generally unconvincing literature describes
catecholamine-induced stimulation, inhibition, and non-regulation of
Na+,K+-ATPase activity (for review, see Phillis et a1., 1981 and Gadsby,
1990). Direct regulation of the enzyme by neurotransmitters in brain has
been difficult to demonstrate for two reasons. First, in broken cell
preparations, catecho1amines appear to nonspecifical1y enhance Na+, K+­
ATPase activity by chelating divalent metal ions that normally inhibit the
enzyme (Van der Krogt et a1., 1980). Second, activity of the enzyme is
dependent upon and extremely sensitive to the Na+ and K+ concentrations
near the cell membrane which may be altered as a result of
neurotransmitter binding and ion channel activation (Gadsby, 1983).
Indeed, the hyperpolarizing actions of catecholamines on sympathetic
ganglia, once thought to be due to direct stimulation of Na+,K+-ATPase,
have been determined to arise from an increased potassium conductance
which elevates the extracellular potassium concentration and thereby
indirectly modulates the enzyme's kinetics (Smith, 1984).
In contrast, the inhibition of Na, K-ATPase by dopamine described
here must reflect direct neurotransmitter induced changes in either the
enzyme itself or a closely associated molecule. Intact cells were
preincubated with dopaminergic compounds, and then permeabi1ized by cold
shock to load them with 32p-ATP and stabilize intracellular Na+
concentration at 70 mM. This procedure should have dissipated any
neurotransmi tter-induced changes in ion concentrations before enzyme
activity was measured. The inhibition cannot be explained by a down
regulation in the number of membrane inserted Na+ ,K+-ATPase molecules since
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the ATP hydrolysis assay measures activity from both plasma membrane
inserted and internalized pumps.
The present results provide strong evidence in support of the idea
that activation of both Dl and D2 receptor subtypes is required for the
inhibition of Na+,K+-ATPase activity. An extensive literature describes
an interaction between the Dl and D2 receptor subtypes in brain despite
the fact that the receptors differ in their anatomical distributions and
pharmacological profiles and mediate distinct behavioral and
electrophysiological effects (for review, see Clark and White, 1987).
Synergism has previously been demonstrated on both the behavioral and
electrophysiological levels; Dl and D2 receptor co-activation is required
for the expression of dopamine-induced stereotypic behaviors in the rat
(Walters et al., 1987) and Dl receptor stimulation is required for the
inhibition of nucleus accumbens neurons by D2 receptor agonists (White,
1987).
It is not clear at what level of cellular organization such
synergism is occurring since Dl and D2 receptors are widely but unevenly
distributed across the cell types of the basal ganglia and their
subcellular distribution is unknown (Richfield et aI, 1989). The co-
activation of both receptor subtypes required for many dopamine-mediated
effects could reflect interaction of receptors on a single cell, on
different cells from the same brain region or on cells from different
brain regions. Dopamine receptor synergism has previously been postulated
to reflect interactions between Dl receptors of the substantia nigra and
D2 receptors in the neostriatum (Robertson et al., 1987). The synergism
required for the Na+,K+-ATPase inhibition demonstrated here, however, must
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be occurring on the level of single cells. Assays were conducted on a
dissociated cell population, nearly homogeneous morphologically, and
lacking synaptic contacts. 01 and 02 receptor co-activation resulted in
a synergistic inhibition of Na+, K+-ATPase activity distinct from the
additive effect expected from subpopulations of neurons each containing
only one of the two receptor sUbtypes.
The biochemical mechanism of this synergism must reflect the signal
transduction mechanisms of the 01 and 02 receptors in striatal neurons.
02 receptor activation in striatal neurons inhibits adenylate cyclase
activity via the inhibitory G-protein Gi (Ohara et al., 1988). In
pituitary lactotrophs, 02 receptor activation has a second coupling
mechanism to polyphosphoinositol hydrolysis (Vallar et al., 1989). In
striatum, D2 receptor activation is not thought to be coupled to this
second pathway and may instead be linked to calmodulin translocation and
calcium-regulated protein phosphorylation (Rubinstein et al., 1990; Lau,
1984).
Dl receptor activation in neostriatum leads to adenylate cyclase
activation, cAMP formation and the activation of cAMP-dependent protein
kinase (Hemmings et al., 1987). This kinase phosphorylates members of the
ARPP family of basal ganglia-enriched phosphoproteins (Walaas et al.,
1983a). One of these phosphoproteins, DARPP-32 (a dopamine and cyclic AMP
regulated phosphoprotein, Mr= 32,000), is co-localized in cells which have
Dl receptors and has been shown, in striatal neurons, to be phosphorylated
in response to dopamine (Walaas et al., 1983b). Guinea pig medium spiny
neurons contain high levels of this protein as shown in Figure 27. DARPP-
32, when phosphorylated, becomes a potent inhibitor of a promiscuous
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phosphatase, protein phosphatase-I. Phospho-DARPP-32 therefore can be
considered to potentiate the phosphorylation of substrates by protein
kinases by inhibiting the reverse dephosphorylation reaction (Hemmings et
al., 1987). Intracellular loading of renal tubule cells with phospho­
DARPP-32 inhibits Na+,K+-ATPase activity (Aperia, personal communication).
Based on this information, a model for the receptor synergism
underlying Na+,K+-ATPase inhibition can be constructed (Figure 28). For
simplicity, the functional unit of Na+,K+-ATPase regulation can be
considered to be a Na+,K+-ATPase complex, consisting either of the enzyme
alone or the enzyme in close association with a regulatory molecule. The
complex can exist in two forms: dephosphorylated and ion translocating,
and phosphorylated and inhibited. D2 receptor activation increases
intracellular levels of diacylglycerols, Ca* ions etc. which activate an
unidentified kinase, protein kinase X. This kinase phosphorylates the
Na+ ,K+-ATPase thereby inhibiting its activity. Dl receptor activation
stimulates cAMP-dependent protein kinase which phosphorylates DARPP-32
which in turn inhibits protein phosphatase 1. Phosphatase-l inhibition
prevents the dephosphorylation of the Na+,K+-ATPase complex thereby
potentiating the phosphorylation of the complex by protein kinase X. This
model for Dl and D2 receptor synergism is currently being tested in renal
tubule cells which contain DARPP-32 and in which Dl and D2 receptor
activation also acts synergistically to inhibit Na+ ,K+-ATPase activity
(Meister et al., 1989; Bertorello et al., 1988b).
Of particular interest is the identification of the molecule that
may be phosphorylated. Indirect evidence for inhibition of Na+,K+-ATPase
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Figure 28 Hypothetical model for Dl and D2 synergistic inhibition of
Na+,K+-ATPase activity. D2 stimulation activates an unidentified protein
kinase, kinase X, which phosphorylates and inhibits the Na+ ,K+-ATPase
complex. This complex may be the ATPase itself or the ATPase in close
association with a regulatory molecule. Dl receptor activation
potentiates this inhibitory effect by activating DARPP-32. Phospho-DARPP
inhibits protein-phosphatase-l and the dephosphorylation of the complex.
An alternative Dl pathway is that cAMP-dependent protein kinase directly
phosphorylates the Na+,K+-ATPase complex on a site separate from the site
that is phosphorylated by protein kinase X. The two sites could then act
cooperatively to inhibit the enzyme.
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membranes (Lingham et al., 1983). The putative intracellular domains of
the Q catalytic subunit contain consensus amino acid sequences for
phosphorylation by several protein kinase (Nairn, personal communication) .
Catalytic subunit of cAMP-dependent protein kinase has been reported to
phosphorylate a protein in kidney membrane extracts which migrates on
polyacrylamide gels in a similar position to the Q subunit (Mardh, 1983).
The micromolar concentrations of Dl and D2 agonists used to inhibit
Na+ ,K+-ATPase activity suggest that the observed regulation of enzyme
activity by dopamine may have physiological significance. Inhibition of
the electrogenic Na+,K+-ATPase leads to transient membrane depolarization
and a rise in intracellular Na+ in excitable cells (Phillis and Wu, 1984).
In cardiac Purkinje fibers, pump inhibition by strophanthidin produces an
8 mV depolarization of the membrane potential (Gadsby et al., 1979).
Attempts to measure dopamine modulation of striatal cell excitability
using patch clamp techniques were unsuccessful due to the small size of
the pump current relative to leakage through more rapidly conducting ion
channels. Although the channels can be pharmacologically blocked, the
small size of the pump current « 3 pA) makes detection of its modulation
a formidable task. The extent and time-frame of the presumed
depolarization of the striatal neurons by inhibi ting the electrogenic
Na+,K+-ATPase remains to be determined.
Regulation of Na+,K+-ATPase activity has been implicated in both the
development and pathology of the nervous system. Neuronal differentiation
of the amphibian embryo can be inhibited if Na+ ,K+-ATPase activity is
reduced (Breckenridge et al., 1982) and neurotrophic agents such as nerve
growth factor are necessary to maintain the enzyme's activity during
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development (Skaper et al., 1986). Low Na+,K+-ATPase activity is found in
the brains of patients with Alzheimer's disease and lower activity in
erythrocytes is correlated with bipolar affective disorders (Liguri et
al., 1990; Hokin-Neaverson et al., 1989). Inhibition of Na+ ,K+-ATPase
activity in hippocampal slices leads to an increase in extracellular K+ and
onset of spreading depression, a model for seizure activity (Haglund et
al., 1990).
The present results suggest that dopamine, in addition to its
regulation of ion channels (see Chapter 4), regulates cell excitability
through the novel mechanism of pump inhibition. If this is so, then this
action of dopamine on Na+,K+-ATPase activity may be an important component
of the mechanism by which this neurotransmitter alters the responsiveness
of dopaminoceptive neurons to other neurotransmitters such as glutamate




This thesis describes three different signal transduction
mechanisms, each of which may be mediated or modulated by protein
phosphorylation. The rate of desensitization of the nicotinic
acetylcholine receptor (nAchR), a chemically-gated ion channel, is
dependent upon the stoichiometry of phosphorylation of the receptor.
Dopamine receptors are coupled both to ion channels and to an ion pump,
the Na+,K+-ATPase, through a mechanism involving second messenger
activation and protein phosphorylation. These different receptor-effector
mechanisms illustrate two themes of signal transduction. A given cellular
response may be subject to multiple first messenger controls as in the
case of the nAchR. Alternatively, stimulation by a single first
messenger, such as the activation of Dl and D2 receptors by dopamine, can
result in divergent physiological responses.
Convergence of cellular signalling can be seen in the regulation of
desensitization of the nAchR. Three different kinases, cAMP-dependent
protein kinase, protein kinase C and a tyrosine-specific protein kinase,
each phosphorylate a common region of the receptor increasing its rate of
desensitization. The neurotransmitters and hormones responsible for the
physiological regulation of the activity of the different protein kinases
have been investigated recently. Calcitonin gene-related peptide (CGRP)
is a co-transmitter with acetylcholine at the neuromuscular junction which
raises intracellular cAMP levels (Laufer et al., 1987). CGRP binding to
cultured myotubes increases the rate of nAchR desensitization and
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stimulates phosphorylation of the a and 0 subunits of the receptor in an
identical pattern to that elicited by cAMP-dependent protein kinase (Mulle
et al., 1988; Miles et al., 1989). Acetylcholine itself may be the first
messenger that regulates phosphorylation of the nAchR by protein kinase C.
The nicotinic agonist, carbamylcholine, stimulates phosphorylation of the
receptor in a pattern similar to that elicited by protein kinase C (Miles
et al., 1990). Protein kinase C may therefore be activated by calcium
ions that permeate the receptor channel during agonist binding.
Regulation of signal transduction by tyrosine phosphorylation is a new,
uncharacterized pathway. The factors that regulate tyrosine
phosphorylation of the receptor are unknown but are likely to be molecules
co-released with acetylcholine at the neuromuscular junction. The nAchR
is therefore regulated by three protein kinase systems that are activated
by at least three independent first messenger systems leading to a common
functional modulation of the receptor (Figure 29).
The functional role of receptor desensitization in the nervous
system has been controversial. In classic neuromuscular junction
preparations, desensitization develops only after seconds of agonist
application or extremely high frequency stimulation (Katz et al., 1957).
At nicotinic synapses, however, acetylcholine is present for millisecond
long pulses, suggesting that desensitization does not have time to develop
in vitro. Accordingly, receptor desensitization has been traditionally
assigned the mundane function of a safety mechanism to make cells
refractory to overdoses of agonist.
Two recent lines of evidence suggest that desensitization is a









Figure 29 Schematic diagram illustrating proposed regulation of the
nAchR by three different first messenger systems. CGRP, acetylcholine and
an unidentified neurotransmitter, through the activation of their
respective receptors and associated kinase systems, each brings about the
phosphorylation and increased desensitization rate of the nAchR. (From
Huganir et al., 1987)
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synaptic level (Changeux, 1984). First rapid flux and
revealed a rapidly developingelectrophysiological measurements have
desensitized state following millisecond long exposures to acetylcholine,
providing a mechanism for desensitization to be manifested on a
physiologically relevant time scale (Hess et al., 1979; Magleby et al.,
1981). Second, several energy-expensive phosphorylation pathways have co­
evolved to modulate the desensitization process, suggesting that it plays
an important role in neuronal function. Modulation of the stoichiometry
of phosphorylation, and thereby the potential inactivation of receptors,
provides a mechanism for cells to regulate their sensitivity to incoming
signals. The biphasic desensitization process at the nAchR creates
several potential time frames of regulation. Desensitization over
milliseconds to seconds may regulate the decay rate of synaptic currents
and responses to closely-spaced repetitive stimuli. Slower
desensitization rates may serve to tonically inhibit nicotinic synapses.
The molecular mechanism underlying desensitization is not well
understood. At least three desensitized states exist which can be
distinguished by the millisecond, second and minute time frames at which
they develop. Desensitized nAchRs bind agonist with a higher affinity
(Ko=3 to 5 nM) than receptors in the resting state (Ko=50 to 100 nM) (Boyd
et al., 1980). Spectroscopic evidence suggests that the desensi tized
receptor has a different conformation than basal receptors (Barrantes,
1978). Phosphorylation is likely to regulate desensitization by enhancing
this conformational change of the receptor to a non-conducting state by
modifying the charge around amino acids that are critically involved in
the transition. Phosphorylation does not change the initial binding of
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acetylcholine to the Q subunits (Huganir et al., 1986).
Receptor desensitization appears to be a common mechanism of
regulation of chemically-gated ion channels. The kainate/quisqualate
subtype of glutamate receptor desensitizes within 10 milliseconds of
agonist application (Trusell et al., 1988). GABAA receptors also
desensitize and, interestingly, this desensitization is enhanced with
forskolin application (Tehrani et al., 1989). Protein phosphorylation may
therefore be a common mechanism for modulating desensitization across
members of the receptor-gated ion channel family.
The action of dopamine on striatal neurons is an example of a
divergent signal transduction pathway in which one neurotransmitter system
is coupled to several intracellular cascades. Dopamine, acting on both DI
and D2 receptor subtypes, has both antagonistic and synergistic effects in
the basal ganglia. These divergent actions can be explained, in part, by
activation of either ion channels or ion pumps.
Antagonism of DI and D2 receptor sub type s can be seen at the
biochemical, electrophysiological and behavioral levels. DI and D2
receptor activation is oppositely coupled to adenylate cyclase activity,
GABA release, firing frequency and stimulation of locomotion (for review,
see Clark et al., 1987). These antagonistic actions have led to the
traditional classification of Dl receptors as excitatory and D2 receptors
as inhibitory. The transient voltage-dependent outward conductance
coupled to D2 receptors described in Chapter 4 provides a molecular basis
for this antagonism (Figure 30). D2 receptor stimulation, by enhancing
this outward current at membrane potentials postive to -60 mV, will tend







Figure 30 Schematic illustration of a proposed model for Dl and D2
receptor antagonism in striatal neurons. D2 receptor activation enhances
an outward current through a G-protein linked potassium channel. D2
receptor stimulation also inhibits adenylate cyclase activity thereby
downregulating cAMP-dependent protein kinase. Dl receptor stimulation
activates adenylate cyclase leading to the production of cAMP and
activation of cAMP-dependent protein kinase. This kinase phosphorylates
an unidentified substrate (probably the D2 receptor, its associated G­
protein or the ion channel) which uncouples the receptor-channel linkage.
110
activation, by activating cAMP-dependentprotein kinase and functionally
uncoupling the D2 receptor from the conductance, may abolish this
inhibitory response.
Synergism of Dl and D2 receptors in the basal ganglia is frequently
described in behavioral studies in which the behavioral sequelae of D2
receptor occupancy appear to require Dl stimulation for their expression
(Gershanik et al., 1983). Dl and D2 receptor coactivation produces
potentiated responses in nucleus accumbens and globus pallidus as assayed
by extracellular recording techniques (Carlsson et al., 1987). Although
some synergism undoubtedly reflects interactions across neurons,
regulation of Na+,K+-ATPase activity by the combined signal transduction
pathways of the Dl and D2 receptors provides a molecular mechanism for
synergism at the level of single cells (Figure 31). In this hypothetical
model, as described in Chapter 5, Dl and D2 receptor stimulation activates
two protein kinase systems one of which phosphorylates the ATPase complex
and inhibits ion translocation while the other inhibits the reverse
dephosphorylation reaction.
The physiological result of Dl and D2 receptor co-activation on a
single striatal neuron may depend on which of these two dopamine signal
transduction mechanisms (channel conductances or Na+,K+-ATPase regulation)
is operating. The subcellular distributions of Dl and D2 dopamine
receptors and the Na+,K+-ATPase are not known. The relative contributions
of these two transduction systems to the neuron's electrophysiological
state and decision to fire are therefore difficult to estimate. It is
likely, however, that there is heterogeneity across striatal neurons in










DARPP 32 __. Phospho- DARPP-32
Figure 31 Schematic illustration of a proposed model for Dl and D2
receptor synergism in striatal neurons. D2 receptor occupancy activates
protein kinase X which phosphorylates the Na+, K+-ATPase, converting it from
an ion translocating pump to an inactive molecule. Dl receptor occupancy
stimulates cAMP-dependent protein kinase which phosphorylates DARPP-32.
Phospho-DARPP-32 inhibits protein phosphatase 1 and the dephosphorylation
of the ATPase back to an ion trans locating pump. cAMP-dependent protein
kinase may also directly regulate the Na+,K+-ATPase by phosphorylating the
ATPase. For simplicity, the site of phosphorylation is drawn as an
intracellular portion of the Na+,K+-ATPase molecule but the data do not
preclude the existence of a closely associated regulatory molecule as the
phosphorylated moiety.
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and D2 specific probes has revealed that although most striatal neurons
express mRNA for the D2 receptor, only 50% of striatal neurons express
mRNA for the Dl receptor (Mansour et al., 1990; Sunahara et al., 1990).
Both receptor subtypes are co-expressed, therefore, in only a
sUbpopulation of striatal neurons. This suggests that some striatal
neurons will exhibit pure Dl or D2-specific responses to dopamine
application and other cells may have more complex responses reflecting the
antagonistic and synergistic interactions of both receptor subtypes.
Mammalian neostriatum is not homogenous and is compartmentalized
into striosome and matrix regions that are distinguishable by their
neuropeptide content and the cortical layer of their afferent projections
(Graybiel, 1990). Although the dendritic morphology and resting membrane
properties of medium spiny neurons appear to be identical in the two
compartments (Kawaguchi et al., 1989), an unexamined question is whether
they differ in their distributions of dopamine receptors and therefore in
their physiological responses to the neurotransmitter. Since
striosome/matrix boundaries can be visualized only in fixed tissue stained
for specific peptides, dopamine electrophysiology is blind to the origin
of the sampled cells. The molecular basis of Dl and D2 signal
transduction, how these mechanisms are modulated by protein
phosphorylation and interact within a cell and how this interaction varies
across the cells of the basal ganglia, await further investigation.
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